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INTRODUCTION 
The respiratory form of infectious bovine rhinotracheitis (IBR) 
caused by Bovid herpesvirus-l was first recognized as a distinct clinical 
entity in Colorado (Miller 1955) and California (Schroeder and Mays 1954) 
during the early 1950's. McKercher et al. (1955) and Jensen et (1955) 
initially described the clinical signs of hyperthermia, anorexia, coughing 
and mucopurulent discharge from the nostrils. Examination of the trachea, 
pharynx, tonsils and adjacent lymph nodes at necropsy often revealed 
extensive ecchymotic hemorrhages and focal necrotic ulceration. Histo­
pathologic changes induced by the causative agent included acute to sub­
acute necrotic rhinotracheitis especially prominent on the nasal septum, 
pharynx and anterior one-third of the trachea. 
Madin ^  al. (1956) isolated the causative agent, a virus, from the 
nasal washings of experimentally infected calves. Their experiments 
clearly indicated that this virus, when inoculated intranasally into 
susceptible calves, caused disease with characteristic signs of the 
natural illness. The morphological and biophysical characteristics first 
defined by Tousimis (1958) and Armstrong £t al. (1961) are typical of 
the herpes virus group. The virus is generally referred to as IBR virus 
(IBRV) even though the suggestions of viral taxonomists (Andrews 1954; 
Roizman et al. 1973) prompted investigators to use such terms as herpes 
virus bovis (Nelson e^ al. 1972), bovine herpesvirus 1 (Michalski et al. 
1976), -nd bovid herpesvirus 1 (Cilli and Castrucci 1976; Smith 1977). 
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A disease of cattle known as blMschenausschlag, coital exanthema or 
infectious pustular vulvovaginitis (IPV) was described in Europe in 1890 
(Fenner 1890). Since that time it has been shown to be worldwide in its 
distribution. Gillespie et al. (1959) failed to show distinct differences 
between IBRV and IPV virus; therefore, references to IBR/IPV virus may 
often be found in the literature. 
The diverse clinical manifestations of IBRV infection include bovine 
respiratory disease (Madin ^  al. 1956), conjunctivitis (Abinanti and 
Plummer 1961), vulvovaginitis, balanoposthitis (Grieg et al. 1958), 
abortions (Owen et al. 1964), and meningoencephalitis (French 1962; 
Barenfus and Schroeder 1963; Durham 1974). Though viral isolants made 
from these conditions seem to have a biological predilection for certain 
tissues, no unequivocal serologic, morphologic or biochemical differences 
in these strains have been demonstrated. 
The persistent or chronic nature of IBRV infections has been 
demonstrated. Snowden (1965) was able to repeatedly isolate virus from 
experimentally infected cattle for as long as 578 days after initial 
exposure. Huck ^  (1973) reported evidence to support the theory 
of long term chronic IBR/IPV virus infection in maiden heifers. Male 
genital organs may also be chronically infected with the virus; there­
fore, the potential exists for venereal transmission through natural and 
artificial breeding (BBttcher and Mahler 1970), The failure of modified 
live virus vaccine to eliminate IBRV-induced respiratory disease from 
feedlot cattle (Kiesel et 1972; Curtis and Angulo 1974) even though 
many of the individuals may have been vaccinated 2 or 3 times (Jensen 
3 
et al. 1976) raises serious doubts about the effectiveness of these 
vaccines or the wisdom displayed by advocating their widespread use. 
Although vaccine induction of resistance to experimental challenge 
exposure may be demonstrated it is reasonable to expect that 
environmentally-induced stress-related immunosuppression or other 
viral infections (Mensik ^  al. 1976) may reactivate chronic IBRV 
infections. Chemically induced recrudescence of natural (Dennett et al. 
1973; Dennett et ^  1976). and experimental (Sheffy and Davies 1972; 
Sheffy and Rodman 1973) IBRV infections have been demonstrated. The 
modification of cell-mediated immune response by other viral infections 
could conceivably play a role in immunosuppression and IBRV reactivation 
(Mensik et a^. 1976). 
Hypersensitivity reactions (Darcel and Doward 1972; Gir6n et al. 
1975) to herpesviral antigens in animals previously infected with herpes­
viruses suggests that the recovery from infection, recrudescence of 
chronic infections and resistance to disease may be intricately related 
to cell-mediated immune (CMI) mechanisms. The general knowledge of the 
pathogenicity and epidemiology of herpesvirus infections could be 
enhanced by using CMI techniques to evaluate the pathologic and immuno-
biologic changes that occur during acute, chronic, and chemically 
reactivated IBRV infections in cattle. 
The objectives of these studies were to determine the effective­
ness of immunosuppressive agents to cause recrudescence of chronic IBRV 
infections of cattle, to evaluate the histopathologic changes that occur 
in cattle due to chemically-induced reactivation of IBRV infections, to 
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compare changes in various immune mechanisms during immunosuppression, 
and to determine the effect of acute IBRV infections in immunosuppressed 
calves. Information provided by accomplishment of these objectives 
could provide valuable knowledge concerning the pathogenesis of IBRV 
infections in cattle and insights leading to improved methods of 
producing resistance to herpesvirus infections in all animals. 
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LITERATURE REVIEW 
One of the most perplexing, yet intriguing virus-host relationships 
observed in nature is the interactions between herpesviruses and the 
multicellular organisms they infect. The research maze that surrounds 
this phenomenon is almost incomprehensible. Many theories are perpetrated 
to explain all or a portion of these well-known disease processes, and 
subsequent immunological relationships. Efforts to explain this mechanism 
have not abated since that so succinctly described by Du Castel in 1901 
when he stated that "In our ignorance of the exact process of herpes, 
each medical generation creates a theory adapted to the ideas and 
discoveries of the moment" (quoted by Nahmias and Dowdle 1968, p. 111). 
The Nature of Herpesvirus Infections 
Much of the present knowledge of the pathogenesis of herpesvirus-cell 
interactions has been developed from the study of human herpesvirus 1 
(Herpes simplex virus, HSV-1). A comprehensive review of the history 
of disease recognition and early research efforts with this virus is 
recorded by Nahmias and Dowdle (1968). They credit Herodotus, the 
Roman physician, as being the first to describe the disease with the 
statement, "the herpetic eruptions appeared about the mouth at the crisis 
of simple fever." 
The perpetuation of viral diseases requires a mechanism for the 
causative virus to survive in nature. The obligate nature of viral 
replication in living cells mandate a host-to-host transfer, an 
equilibrium of compensatory virus cell interaction, or a state of 
latency. The terminology describing persistent viral infections of 
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host cells is not well-defined. Fenner (1968) used the term latency in a 
general sense, but Johnson (1970) used the term in a restricted sense 
to give the connotation of the covert nature of virus-cell relationships. 
Dulbecco's (1965) enunciation of the maintenance of equilibrium conditions 
of viral persistence in the cell depending upon the degree of cytocidal 
activity of the relationship brought some order to this controversy. His 
designation of a steady state of independent virus-cell interaction (IVCI), 
in which a noncytocidal infection of all cells occurs and dependent virus-
cell interaction (DVCI) where a minority of cells are cytocidally infected 
and synchronous replication of the nucleic acid of both the cell and virus 
occurs with a minute amount of spontaneous release are useful designations. 
Jack (1974) reviews the use and meaning of these terms and uses 4 human 
herpesviruses to illustrate the type of host cell-virus relationships 
that exist. He places all viral infections into 2 major divisions, acute 
and nonacute infections. Acute infections refer to the classical type 
described by Fenner (1968) and Johnson (1970) with primary interaction of 
the virus and host cell and viral replication with or without cell death. 
This infection is eliminated or progresses on to the nonacute state. The 
nonacute stage is subdivided into chronic, latent or covert, and slow 
infections. The chronic infection is divided into continuously detectable 
and discontinuously detectable. The slow infections are subdivided into 
slow-degenerative and slow-neoplastic. A salient feature of this scheme 
then becomes apparent in that, in true latency or covert infections, the 
virus must be completely undetectable in the interval following recovery 
from acute infections until exacerbation of the illness due to recrudescence 
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of the virus, with recurrent illness that would progress through stages 
exhibiting features typical of the acute infection. The outline form 
developed below aids in understanding Jack's (1974) conclusions: 
I Acute Infections - detectable virus with or without cell death 
II Nonacute Infections 
a. Chronic 
1. Continuously detectable 
2. Discontinuously detectable 
b. Latent or covert - either integrated cell virus 
nucleic acids or undetectable 
c. Slow 
1. Slow degenerative 
2. Slow neoplastic 
Jack (1974) suggests that human cytomegalovirus infections are 
predominantly chronic infections that may show both continuous and 
discontinuous excretion from the host, with the degree of detectability 
dependent upon the age of the host at the time of primary infection, or 
subsequent state of health, such as hormonal influences and intense chemo­
therapy with cytotoxic substances. He describes the host virus rela­
tionship of Varicella-Zoster Virus (VZV) as an example of the latent or 
covert state. The appearance of zoster (shingles) in adult life following 
childhood Varicella (chicken pox) virus infection usually represents a 
single attack. The zoster syndrome may also occur in children if pro­
voked by disease or chemotherapy. Each person so affected gives a 
reliable history of varicella infection or chicken pox in childhood. 
The facts that zoster patients can transmit Varicella virus (and not 
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vice versa), that no biologic or serologic differences can be detected 
in VZV strains, and that there are long intervening periods of lack of 
virus detection indicating a true covert or latent infection. The recur­
rence of active lesions at unusual anatomical sites led to the speculation 
that the initiator of the second attack must be the sensory ganglion 
supplying the cutaneous area involved. This theory is further enhanced 
by the evidence of acute inflammatory process in the regional ganglion 
of infected areas in fatal zoster cases. Jack states that "it is tempting 
to view the mitotically inactive neurone as the site for the long-term 
persistence of VZV," and if so, this would not necessitate a hypothesis 
of viral integration with host DNA. However, he further admits that 
if the virus is present in the satellite or glial cells that are capable 
of mitoses then an integrated state may be necessary to maintain it for 
long periods of time. Cytotoxic and steroid therapy, neoplasia and 
other infections may activate VZV infections but unlike CMV there is no 
ensuing chronicity or generalized spread, which indicates that the patho­
genic or immune mechanisms are quite different. 
The theory of Epstein-Barr Virus (EBV) is truly a covert or latent 
infection gains support from the fact that partial integration of the 
genome in blastoid lymphocytes has been demonstrated. Further evidence 
to support this position is found in the fact that conditions that induce 
lymphoid hyperplasia such as leprosy, sarcoidosis, lupus erythematosus 
and Hodgkiris disease also cause increased activity of endogenous EBV. 
The establishment of lymphoblastoid cell lines only from lymphocytes 
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infected with EBV and its association with Burkitt's lymphoma and 
nasopharyngeal carcinoma indicates that this latent cell-virus 
relationship may also be carcinogenic. 
The exact nature of the cell-virus relationships in nonacute HSV 
infections in humans is not known. Jack suggests that covert relation­
ships analogous to the latency of VZV may exist in some individuals, 
whereas chronic infections with discontinuous excretion occurs in others. 
In a review of literature relating to the role of nervous tissue in 
maintenance of the chronic or latent nature of herpesvirus infections in 
man and experimental animals, Baringer (1975) concludes that the most 
significant HSV spread from the initial site of infection is through 
neuronal axon flow mechanisms, even though there is some evidence to 
indicate that contiguous cell-to-cell spread may occur along the sup­
porting Schwann satellite cells of the nerve fibers and ganglions. 
A predominant number of reports by competent investigators seem to 
support the view that the neuron of the sensory ganglion innervating the 
site of epithelial lesion recurrence provides the essential milieu for 
residence of the virus for prolonged periods. Baringer (1975) concedes 
that at present the scientific evidence is insufficient to determine the 
exact mechanism involved in the neuron-virus relationship and the patho­
physiological alterations within the host that trigger renewed virus 
replication within the ganglion and subsequent epithelial lesions in 
areas that it innervates. Two basic theories to explain this immuno­
logic phenomenon have gained a degree of prominence. 
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First, the theory proposed by Roizman (1965) is palatable because 
it agrees with the supposition that mammalian viral latency is comparable 
to the prophage state of lysogenic bacteria. This theory contends that 
viral replication is restricted in a static state within virogenic cells, 
but the potential for that replication is preserved by the incorporation 
of the viral genome within chromosomes of the neuron. The work of 
Yamamoto e^ (1977), showing a HSV directed peak of thymidine kinase 
activity 46 days longer than infectious virus could be detected, tends 
to support this theory. 
The second theory, described in some detail by Ennis (1973), proposes 
that HSV exists in a dynamic state within low metabolic neurons of the 
ganglion, in which the productive viral replication and related cytopatho-
logic changes are effectively restricted by humoral and cellular host 
defense mechanisms. Recent investigations by Walz ^  (1976) indicate 
that the number of chronically infected ganglia and subsequent recurrence 
may be directly related to the effectiveness of viral replication at the 
initial site of infection, and the ability of the host to respond immuno­
logically to the infection. 
Recrudescence of Herpesvirus Infections in Man 
The precipitation of recurrent herpesvirus eruptions in man is known 
to be associated with a number of quite variant biophysical conditions. 
Such conditions as elevated temperature, exposure to ultraviolet light, 
strong winds, menstruation, emotional stress or physical trauma may evoke 
recurrent eruptions. The stress of pregnancy may potentiate primary HSV 
infections into generalized disseminated disease (Young ^  ai* 1976). 
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The common physiologic impact, of any, of these conditions is not known. 
Several methods of experimental induction of recurrent lesions have been 
successful. Good and Campbell (1948) reported that anaphylactic shock 
would induce recurrence of HSV in chronically infected mice. Other 
workers have shown that treatment with corticosteroids (Thygeson et al. 
1953), epinephrine (Schmidt and Rasmussen 1960; Laibson and Kibrick 1966), 
and the induction of Arthus reaction may also cause the exacerbation of 
chronic HSV-1 infections in experimental animals (Anderson e^ 1961). 
The exact mechanism involved in the variation of the host response 
to acute infections, the recovery from acute infections, the resistance 
to re-exposure to exogenous virus, and the development of lesions due 
to indogenous chronic or latent virus is not completely understood. 
Since recurrent lesions appear in patients with high serum antibody 
titers, most investigators believe that some other immune mechanism 
plays a predominant role. Recent investigations (Zisman al. 1969; 
Mori £t 5^. 1967) have shown that macrophages and thymus derived (T) 
lymphocytes are key factors in controlling chronic HSV infections in 
mice. An elegant series of experiments by Rager-Zisman and Allison 
(1976) using cyclophosphamide-treated HSV-infected mice has indicated 
that protection against this virus infection is predominantly T cell 
dependent. Their results also indicate that the macrophage plays an 
important role in the host's recovery process. Their studies seem to 
imply that humoral antibodies alone play no major role in the recovery 
of the host. However, they suggest that the data tends to support the 
theory that antibody-dependent cell-mediated cytotoxicity may well be 
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operative in this specific incidence. Blank and Haines (1976) demon­
strated that patients with recurrent HSV infections and high antibody 
titers could easily be super-infected in epithelial tissues at remote 
sites from recurrent lesions with both indigenous and exogenous virus. 
They seem to believe that humoral antibody plays little or no role in 
preventing recurrent or exogenous HSV infections. 
Latent Herpesvirus Infections in Other Animals 
The mouse cytomegalovirus is another example of a chronic herpes­
virus infection with discontinuous detectable excretion (Medearis 1964) 
but it appears that a latent infection may exist in lymphoid tissue. 
Olding et al. (1975) demonstrated more specifically that the latent 
infection resided within the B lymphocyte population and that the virus 
could be recovered readily from lipopolysaccharide-induced blastogenesis 
of B lymphocytes from chronically infected mice. 
The infection of guinea pigs with a guinea pig herpesvirus leads to 
a chronic infection from which virus can be isolated from the blood and 
somatic tissue for periods up to 24 months following infection. Pregnant, 
chronically infected animals can transmit chronic infections to fetuses 
(Lam and Hsiung 1971). 
The infection of rabbits by Herpesvirus cuniculi is considered to be 
both discontinuously detectable and latent since virus could be detected 
in some animals as long as 100 days after infection and primary kidney 
cell cultures failed to yield infectious virus but contained viral 
antigen that could be detected by immunofluorescence. 
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Recurrent IBR Infections in Cattle 
The nature of the immune mechanisms responsible for the recovery of 
cattle from acute IBRV infections, resistance to re-infection and the 
recrudescence of chronic or latent infection has not until recently 
been the subject of critical, refined scientific evaluations. The 
role of environmentally-induced physiological stress in IBRV infections 
has been investigated (Bowes et al. 1970; Baczynski et al. 1975; 
Mihaljovîc et 1973), but careful cause-related scientific analysis 
is difficult. The role of shipping stress, hormonal imbalances during 
calving (Snowden 1965), and nutritional deficiencies (Crane 1955) have 
also been suspect. One of the most intriguing theories is based upon 
the fact that certain groups of viruses may suppress the cell-mediated 
immune (CMI) response of acutely infected animals or depress CMI in 
chronically infected animals thereby allowing recurrent disease to 
develop. Myxoviruses have been shown to affect the CMI response in 
other animals. The recent report (Mensik et al. 1976) of reactivation 
of IBRV infection in young calves by experimental PI-3 virus Infection 
tends to support this hypothesis. 
The report by Sheffy and Davies (1972) of the corticosteroid (CS) 
reactivation of IBRV from both naturally and experimentally infected 
cattle sparked a flurry of scientific activity. They reported that 5 
of 6 bulls that had humoral anti-IBRV antibodies for a period of 4 years 
without obvious clinical disease shed IBRV in nasal secretions within 
3-5 days post treatment with dexamethasone. Nineteen pregnant Holstein 
heifers 11 of which had been vaccinated with commercial vaccine, were 
exposed to virulent IBRV and treated with dexamethasone 3-9 months later 
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for a period of 6 or 7 days and slaughtered 24 hours after the last treat­
ment, IBRV was recovered readily from nasal secretions and respiratory 
tract of treated animals, but much less frequently from somatic tissues 
such as nervous tissue, adrenals and reproductive tract. Virus was also 
recovered from the upper respiratory tract and ovarian tissues of 1 of 9 
untreated animals. Sheffy and Rodman (1973) reported corticosteroid-
induced recrudescence of commercial modified live IBRV vaccine given 
2h months previously by the intravenous, intrapreputial and intranasal 
routes. They indicated that even though commercial inactivated IBRV 
vaccine injected intramuscularly evoked humoral antibody development, it 
failed to protect against acute infection or the establishment of chronic 
infections that could be exacerbated with corticosteroids. Davies and 
Duncan (1974) reported the use of dexamethasone and ACTH to induce 
recrudescence of IBRV from cattle experimentally infected by intranasal 
and intravaginal inoculation. In these experiments virus could be 
isolated easily from respiratory and genital tissue 2-5 days post 
treatment. Darcel and Doward (1975) demonstrated that IBRV vaccine 
strain could be recovered from leukocytes and vaginal secretions of CS 
treated cattle six weeks after intramuscular injection of the modified 
live virus vaccine. CS injections have been used to determine that a 
chronic IBRV infection existed in naturally exposed animals (BHttcher and 
Mahler 1970; Huck et al. 1973; Bitsch 1973; Gibbs ejt al. 1975). In each 
instance the synthetic hormone treatment was used as a tool for determining 
the presence of virus in animals that were suspected to be chronically 
infected because they had antibody in their serums. 
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Davies and Carmichael (1973) studied the effect of dexamethasone 
and ACTH upon the cell-mediated immune response during primary and 
recurrent infections. They suggested that suppression of cell-mediated 
immunity, as measured by lymphocyte transformation in whole blood cul­
tures, occurred during CS induced recrudescence but that adrenocortico­
tropic hormone (ACTH) and trigenimal neurectomy induced recrudescence 
without a concomitant immunosuppression. Rouse and co-workers have 
recently published a series of papers (Rouse and Babiuk 1974a, 1974b, 
17975a, 1975b; Rouse et al. 1976; Babiuk and Rouse 1975; Babiuk et al. 
1975) concerning their investigations into the immune mechanisms of acute 
and chronic IBR infections. Their conclusion is that almost all well-
known immune mechanisms play a role in the recovery from, the maintenance 
of, and the recurrence of IBRV infections. 
Ontogeny of Immunocytes and Phagocytes 
The varied expressions of immune responsiveness and resistance to 
disease are a complex of synergistic and complementary antagonistic 
interrelationships of cells and their metabolic products. The current 
knowledge of the ontogeny of these cellular and humoral interactions 
and the Jji vitro methodology used to study them have been reviewed by 
Globerson (1976). The review deals primarily with the embryogenesis, 
mechanisms of developing immunocompetence, and the interrelationships 
of immune responsiveness of B and T lymphocytes and macrophages. The 
synergistic interactions of these three cell populations have been stud­
ied more carefully than others but the role of granulocytic leukocytes 
16 
in resistance to disease, and their potential role in regulating the 
immune response cannot be ignored. 
Ontogeny of the ]B lymphocyte 
The discovery by Click e£ (1956) of the existence of a distinct 
population of immunoglobulin producing cells in chickens that were 
dependent upon their development in the bursa of Fabricius led to the 
current terminology of B-cell or B-lymphocyte. Though there has been no 
agreement on the bursa-equivalent compartment in mammals Globerson's 
evaluation of the research surrounding the controversy seems to indicate 
that: (1) the embryogenesis of the B-lymphocyte in mammals begins in the 
yolk sac with the possibility of some stem cell development in the liver, 
(2) the migration of the stem cell from the yolk sac to the embryonic 
liver where these and indigenous stem cells develop the capability of 
producing immunoglobulin-M, (3) further migration of these precursor B-
lymphocytes to the bone marrow for the final stage of maturation. Thus, 
in mammals, a concert relationship of the fetal liver and the bone marrow 
seems to perform an analogous function as the avian bursa of Fabricius. 
The existence of humoral factors necessary for final stage maturation in 
the bone marrow microenvironment is suspected. The ability of B-lympho-
cytes to produce immunoglobulins is dependent both upon soluble factors 
produced by T-lymphocytes and the physical presence of monocytes. 
Ontogeny of the macrophage 
The macrophage plays an important role in resistance to disease. 
Although Globerson (1976) maintains that the preponderance of scientific 
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literature suggests the progenitor cells of the promonocyte of the bone 
marrow may have its origin in the embryonic liver, he admits that the 
macrophage developing in the bone marrow may originate from other dis­
tinct precursors. This idea is preferred by Gordon and Cohn (1973) in 
their review of the macrophage. Though this controversy has not been 
settled, all agree that the continuing development of immune competence 
takes place in the hone marrow from which the monocyte is released upon 
maturation. The rerie^ by Gordon and Cohn (1973) of the present knowl­
edge of the role of the monocyte details many specific functions of the 
macrophage in the immune response and describes many of their properties. 
They enter the blood stream from the bone marrow and comprise, as 
monocytes, from 3-5% of the circulating leukocytes. Their half-life 
in the blood stream is approximately 22 hours, due to random migration 
between endothelial cells of capillaries. The tissue monocyte matures 
into a more active cell, the tissue macrophage, which divides rarely 
and has a 60 day life span. These cells are particularly prominent as 
Kupffer cells of the liver alveolar macrophages of the lung, and 
histiocytes of the spleen and bone marrow. Macrophages are often 
found in large accumulations, granulomata, in certain local inflammatory 
conditions. These "epitheloid" cells, though less endocytic, may have 
many more mitochondria in their cytoplasm than other macrophages. They 
may fuse to form multinucleated giant cells. Macrophages are highly 
phagocytic in the fetus and neonate but their digestive processes are 
poorly developed at this stage. This enzymatic process develops rapidly 
after birth and may be related to "sensitization" to a multitude of 
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conventional antigens. The role of the macrophage in the immune process 
has many ramifications including phagocytosis, digestion, antigen proces­
sing and interaction with other immunocytes through contact and soluble 
factors produced by the macrophage. 
Ontogeny of the T lymphocyte 
The ontogeny of T cells (thymus processed lymphocyte) reviewed by 
Globerson (1976) can be summarized as follows: The exact origin of the 
primordial cell that differentiates into T lymphocytes is unknown. 
The progenitor cells for T lymphocytes originate in the fetal yolk sac 
and migrate to the thymus ; nevertheless the critical marker (0 antigen) 
for T cell identification in the mouse develops within the microenviron-
ment of the thymus. Certain thymic humoral factors (THF) are necessary 
for the maturation of immature T cells into mature cells bearing the 0 
antigen and having the capability of inducing the graft-versus-host 
(GHV) response. It has also been demonstrated that whereas only the 
THF is required for 9 Ag development, direct contact with viable thymus 
is required for other T cell functions such as T helper activity and 
the GHV response. The exact nature of this essential thymic micro-
environment is unknown. It appears that the T cell function in neonatal 
life lags behind the potential to produce B cell responses. 
Function and Relationship of Immunocytes and Phagocytes 
The intricate developmental and functional relationships between B 
and T lymphocytes have been reviewed by Cooper and Lawton (1974). They 
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contend that both cells arise from a common pluripotential stem cell 
in the yolk sac and follow separate developmental pathways through the 
fetal liver, bone marrow, and thymus to develop varied but interdependent 
functional immune expressions. 
^ lymphocyte function 
The classic expression of humoral immunity mediated through the 
production of immunoglobulins by the plasmacyte (mature B lymphocyte) 
is well-recognized. The principal impact of the B lymphocyte upon 
resistance to disease is through the production of at least 5 well-
defined immunoglobulin (Ig) classes. These Ig molecules (antibodies: 
IgM, IgG, IgA, IgD, and IgE) are synthesized and secreted as a result 
of antigen exposure and are capable of combining with the specific stim­
ulating antigenic moiety upon contact. Claman (1973) points out that the 
Clonal Selection Theory of "one cell — one antibody" of Talmadge and 
Burnet is no longer adequate to explain antibody production, since we now 
know that macrophages and T lymphocytes play important roles in immuno­
globulin production. Their response is mediated through macrophage anti­
gen processing and T "helper" cell stimulation of lymphokine production 
that functions to turn on antigen-specific immunoglobulin production by a 
given B lymphocyte. However, he also points out that some antigens 
can turn on B lymphocytes to immunoglobulin production without macrophage-
T-cell processing. It is interesting that all these antigens are polymers 
(polysaccharides, dextrans, and lipopolysaccharides) and all induce 
antibodies of the IgM class. It is generally recognized (Merigan 1974) 
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that immunoglobulin-mediated disease resistance predominates in such 
viral infections as enteroviruses, flaviviruses and certain myxoviruses. 
2 lymphocyte function 
It has been suggested that cell-mediated immune responses are the 
primary resistance factors in such viral infections as herpesviruses, 
measles virus and visna virus (Allison 1974). T lymphocytes are respon­
sible for the reactions of cell-mediated immunity (CMI) expressed as 
delayed hypersensitivity, allograft and tumor immunity and graft versus 
host reactions and their vitro correlates. Expressions of CMI are 
mediated through the production of several different lymphokines in 
response to specific antigen - T cell interactions. Some of the more 
important factors include: (a) chemotactic factors for monocytes and 
neutrophils; (b) blastogenic factors; (c) macrophage migration inhibition 
factors; (d) factors that enhance the capacity of macrophages to destroy 
intracellular parasites; ( e) interferon; and (f) factors capable of lysing 
target cells (lymphotoxin) (Pierce and Benacerraf 1976). This list of 
T lymphocyte origin factors could be expanded based upon the fact that 
these substances have usually been recognized and described solely upon 
their biologic activities. Therefore, a logical question of the pos­
sibility of a single or a few mediating substances with different biolog­
ical manifestations being related to the assay system has not been ade­
quately answered. David (1973), however, has reviewed the biologic nature 
and physiochemical properties of many of these lymphokines. He concluded 
that even though several of the factors, recognized and named according 
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to biologic reactivity in a specific assay system, may be similar at 
least the six listed above appear to represent different biochemical 
substances. In addition to the secretion of these chemical substances 
by antigen-activated T cells, several other biologic properties of such 
cells are also believed to be important in CMI. Under some circumstances 
activated T lymphocytes appear to be able to act as aggressor or "killer" 
cells when faced with certain specific antigen-induced cell membrane 
alterations (Cerottini et al. 1970a, 1970b). Woodruff and Woodruff (1975) 
suggested that this function may play an important role in recovery from 
and resistance to viral diseases. 
The current knowledge of the functional specificity of T lymphocytes 
has been reviewed by Paul and Benacerraf (1977). They summarize the T 
cell regulatory function upon B lymphocytes in six different categories: 
(1) the stimulation of IgG production; (2) the selection of precursors 
of cells that secrete a given class of Ig and allotypic variants of the 
Ig subclass; (3) the increase in affinity of the specific antibody produced; 
(A) the selective activation of a clonally restricted hapten-specific 
antibody; (5) the expression of common idiotypes on antibody molecules 
specific for distinct antigenic determinants presented on the same carrier 
molecule; and (6) the selection of antibody forming cells which produce 
hapten-specific antibody of opposite negative charge fo the hapten-carrier 
complex. In addition to the positive influence of helper effect of T 
cells upon immunoglobulin production by B lymphocytes, there is considerable 
scientific evidence to indicate that T cells may serve a regulatory function 
upon B cells to depress immunoglobulin over-production or even T cell 
response to specific antigens (Katz 1972; Gershon 1974). 
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Monocyte/Macrophage function 
With the expansion of our scientific knowledge concerning the 
mammalian immune system, it becomes more apparent that the mononuclear 
phagocyte or the macrophage plays a central role in resistance to disease. 
The macrophage-lymphocyte interaction is the main line of body defense. 
Macrophages serve as primary effector cells in amplifying the immune 
response. Its influence is exerted through its interrelationships with 
lymphocytes upon immunoglobulin production by antigen processing and as 
an effector cell in delayed hypersensitivity. The general knowledge of 
macrophage origin and function in resistance to disease has been reviewed 
by Gordon and Cohn (1973) and Unanue (1976). In addition to the classic 
phagocytosis and digestion of invading pathogens and lysosomal enzyme 
secretion, they emphasize the role of the macrophage in modulating the 
activity of surrounding cells and tissues through chemical secretory 
products. These reviews point out that activated macrophages secrete 
several substances that have a regulating effect upon other cell activities: 
(1) a mitogenic principle that is highly stimulatory for lymphocyte pro­
liferation; (2) a substance that promotes the rapid differentiation or 
maturation of B-lymphocytes to the mature plasmacyte-antibody secreting 
cell; (3) an enhancement of T cell function; (4) a colony stimulating 
factor that promotes the proliferation of bone marrow stem cells that 
differentiate into granulocytic and-monocytic phagocytes; (5) inhibitory 
or lytic molecules that seem to depress DNA synthesis and cause certain 
cells to lyse; (6) complement factors, C^, and possibly and C^; 
(7) pyrogens; and (8) interferon. The reviewers hasten to add that since 
23 
these biologic factors have not been identified chemically more than one 
of these activities may be due to a single chemical entity. Allison 
(1974) summarized the current knowledge of the role of macrophages in 
the mammalian immune response to virus infection. He emphasizes the 
well-known fact that one primary function of the macrophage is to 
phagocytize and digest viruses invading the lung and circulating in the 
blood stream to prevent further invasion and multiplication in parenchymal 
tissues. The macrophage-virus relationship then becomes one of extreme 
importance. The ability of certain viruses to replicate within the 
macrophage and thereby spread to nearby tissues is well-known. 
The resistance of certain strains of mice to mouse hepatitis virus 
and yellow fever virus was found to be genetically related to the ability 
of their macrophages to destroy these viruses, whereas the macrophages 
of nonresistant strains supported viral replication. Allison (1974) 
reviews the data that indicate that peritoneal macrophages can be used 
to block lethal herpes simplex virus infections in young mice and that 
macrophages from adult donors do so more effectively than those from 
immature donor mice. The human counterpart is the severe generalized 
herpes simplex infection in newborn children. Allison (1974) is quick 
to point out, however, that scientific investigations support the idea 
that the maturation of macrophages in their virucidal capacity may be 
linked to cell-mediated immunity and stimulation with bacterial or other 
antigens. The recruitment of inflammatory mononuclear phagocytes into 
areas of virus multiplication is a long-recognized phenomenon, and as 
stated previously, there are many indications that immunologically specific 
T lymphocytes are responsible for this chemotaxis in viral infections. 
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Chemical Immunosuppression 
The mode of action of cyclophosphamide 
Cyclophosphamide is one of the most commonly used alkylating agents 
for immunosuppressive therapy. The main site of action of the alkylating 
agents is their interference of nucleic acid synthesis and subsequent 
cell mitosis. These compounds also cause a miscodification of messenger, 
transfer, and ribosomal RNA and thereby interfere with protein synthesis 
(Miescher ^  1976). Turk and Poulter (1972) studied the effect of 
cyclophosphamide treatment upon lymphoid tissue of mice and guinea pigs. 
They found that cyclophosphamide produces a selective depletion upon 
lymphoid cells from the corticomedullary junction and lymph follicles of 
mouse and guinea pig, cervical, axillary and mesenteric lymph nodes fol­
lowing 1 and 3 daily injections of cyclophosphamide at the rate of 
300 to 400 mg/kg body weight. The lymphoid cells around the post capillary 
venules and paracortical areas were spared. Lymphocytes were markedly 
depleted in the lymphoid follicles of the spleen except around the central 
arteriole of the white pulp. In short, their work showed that cyclophos­
phamide treatment caused a selective depletion of lymphoid cells in areas 
classically populated with B cells but had little or no effect upon cells 
in the areas routinely populated with T cells. Stockman e^ al. (1973) 
reported that the effect of cyclophosphamide treatment of mice exerted a 
more severe and longer-lasting depression upon the B lymphocyte than 
upon the T lymphocyte. Turk et al. (1972) reported an increased intensity 
and prolongation of contact hypersensitivity reactions in guinea pigs 
treated with 300 mg/kg body weight of cyclophosphamide. They concluded 
25 
that the treatment did not alter T lymphocyte function but markedly 
reduced B lymphocyte function. Hunninghake and Fauci (1976) studied the 
effect of cyclophosphamide treatment upon peripheral blood leukocytes of 
guinea pigs. They found a marked 5-day sequential reduction in total 
numbers of neutrophils and lymphocytes but no significant reduction in 
monocytes. Askenase £t al. (1975) reported that cyclophosphamide treat­
ment amplified rather than depressed the development of delayed-type 
hypersensitivity of mice to sheep red blood cells. A comparative study 
of the effects of immunosuppressive drugs upon cell-mediated cytolysis 
was conducted by Borel (1976) who reported that corticosteroids caused a 
marked inhibition of this T lymphocyte mediated response but that cyclo­
phosphamide treatment showed no effect upon this activity in mice. 
Pekârek al. (1976) showed that both cyclophosphamide and hydrocortisone 
interfered with the action of the T cell produced lymphokine (MIF) action 
upon macrophage migration inhibition tests. 
Finally, several studies concerning the effect of cyclophosphamide 
treatment upon the recovery and resistance to viral infections have been 
conducted. Rager-Zisman and Allison (1973) studied the effect of cyclo­
phosphamide therapy upon coxsackie B-3 virus infection in mice. They 
found that young adult, cyclophosphamide-treated mice injected intra-
peritoneally with coxsackie B-3 virus developed fatal infections whereas 
nontreated controls developed mild transient infections. They found a 
marked decrease in antibody production, high titers of virus and severe 
lesions in target organs in cyclophosphamide-treated mice but stated 
that the macrophage reactions in virus infected tissues were close to 
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normal. Two reports (Worthington et 1972; Worthington and Baron 
1973) of the effect of cyclophosphamide treatment of vaccinia-virus-
infected mice give solid evidence that drug treatment results in 
increased mortality and decreased antibody production to the virus but 
has no effect upon interferon production and the cell-mediated immune 
response to the virus. McFarland e£ (1972) studied the effect of 
cyclophosphamide treatment of mice upon the characteristic mononuclear 
inflammatory response due to Sindbis virus encephalitis. They found that 
the treatment of mice with a single injection of cyclophosphamide as 
long as 24 hours after intracerebral inoculation with Sindbis virus caused 
ablation of the perivascular mononuclear response characteristic of most 
viral infections. 
Chin and Hudson (1974) studied the ultrastructural changes in mouse 
peritoneal macrophages that occurred following a single intravenous 
injection of a sublethal dose of cyclophosphamide. They found that 
rapid destruction of lymphocytes, neutrophils, eosinophils, and mast 
cells occurred as early as 6 hours following cyclophosphamide treatment. 
The morphology and phagocytizing ability of peritoneal macrophages were 
unchanged by the treatment. Investigations by Turk and Parker (1973) 
indicate that cyclophosphamide treatment enhances and amplifies the 
Jones-Mote type hypersensitivity in guinea pigs but they indicate that 
the potentiating effect of the drug on the reaction is modulated by a 
depression of B lymphocyte function which serves as a moderator of the 
Jones-Mote response. 
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Mode of action of corticosteroids 
Corticosteroids (CS) are used extensively for their anti-inflammatory 
and immunosuppressive effect. However, the exact mechanism through which 
they modify immunologic phenomena is not known. Claman (1975) has reviewed 
the literature concerned with the mode of action of corticosteroids, es­
pecially as it relates to their effect upon the cell-mediated immune 
response. He concludes that even though much of the early literature 
seemed to support the idea that CS acted through their lytic effect on 
T lymphocytes the preponderance of more recent investigations indicates 
that the primary effect is rather upon macrophage function. CS administra­
tion seems to decrease blood levels of monocytes, inhibit the response to 
T cell produced migration inhibition factor and profoundly inhibits 
phagocytic and digestive mechanisms of macrophages. However, the effect 
of CS upon lymphokine production by T lymphocytes is controversial. 
Whereas there are reports (Weston et al. 1973; Barlow and Rosenthal 
1973) that indicate no interference in MIF production by CS, other 
investigations (Barlow e£ al. 1975) provide evidence to indicate that a 
single injection of CS produces no measurable effect on MIF production 
but that continued daily administration caused marked decrease in 
antigen-induced MIF production with depression of cell-mediated lymphocyte 
function. Wahl et al. (1975) demonstrated that pharmacological levels 
of CS inhibited both macrophage chemotactic factor (MCF) and macrophage 
inhibition factor (MIF) production by T lymphocytes. They also showed 
that the drug blocked the action of MIF on macrophages but did not 
interfere with the action of MCF. Fauci (1975) has shown that CS have a 
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two-fold effect upon circulating lymphocytes. First it produces a 
lymphocytopenia related to redistribution of lymphocytes to other body 
compartments, particularly the bone marrow, and secondly a direct inter­
ference by suppressing lymphocyte proliferation. Schlesinger and Israël 
(1975) investigated the effect of CS administration upon different sub-
populations of thymic lymphocytes. They found that Cortisol depleted 
mouse thymic spleen-seeking lymphocytes to a greater extent than the 
population of lymph-node-seeking thymic cells, but that the drug completely 
eliminated the small population of thymus antigen positive lymph-seeking 
cells (those primarily responsible for the cell-mediated immune response). 
Fauci and Dale (1974) also studied the effect of hydrocortisone treatment 
on subpopulations of human lymphocytes and determined that transient 
selective depletion of monocytes and subpopulations of human T lymphocytes 
followed single dose treatments of the drug. Several investigations 
concerned with the effect of CS treatment upon macrophage function have 
been reported (Rinehart e_t a^. 1974; Hunninghake and Fauci 1975; Dimitriu 
1976). The studies of Rinehart _£t al. (1974) indicated that blood mono­
cytes have a unique sensitivity to corticosteroid therapy. They were 
able to demonstrate impaired random movement, specific chemotaxis and 
bactericidal activity of monocytes after only 60-90 min. exposure to 
low levels of hydrocortisone. Their observations suggested that defective 
monocyte function contributes to impaired cellular immune resistance in 
patients receiving corticosteroids. Investigations by Hunninghake and 
Fauci (1975) demonstrated that CS treatment caused a marked decrease in 
cytotoxic effector function of alveolar macrophages by interfering with 
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its capability to bind to the target cell. Dimitriu (1976) studied the 
effect of CS treatment to modify the capacity of sensitized T lymphocyte 
products to induce cytotoxic properties to mouse peritoneal macrophages. 
He found that the effector lymphokine {macrophage arming factor (MAF)} 
production was not impaired but that macrophages from treated animals 
failed to respond to the effects of MÀF during CS treatment. Whether or 
not these impaired functions are related to the stabilization of the 
macrophage lysosomal membranes and impaired intracellular digestion 
(DeDuve et 1962; Weissman and Dingle 1961) and concomitant aggression 
of macrophages to susceptible target cells by exocytosis of lysosomal 
enzymes as suggested by Hibbs (1974) is merely theoretical. 
Many investigators have studied the effect of CS treatment upon the 
production of interferon in virus infected tissues. Their reports 
(Kilboume £l• 1961; DeMaeyer and DeMaeyer 1963; Smart and Kilbourne 
1966a, 1966b; Mendelson and Glasgow 1966; Rytel and Baylay 1973) agree 
that the drug causes a marked reduction in interferon levels in virus 
infected host cells. Results reported by Smart and Kilbourne (1966a, 
1966b) which suggested that cortisone inhibited the action of preformed 
interferon contradicted the investigations of DeMaeyer and DeMaeyer (1963). 
Whereas most of these reports emphasize the importance of interferon in 
recovery from and elimination of viral infections, the work of Rytel 
and Balay (1973) emphasizes that its inhibition by corticosteroid treat­
ment of immunosuppressed patients may play an important role in reactiva­
tion in chronic virus infections. 
Finally, Schreiber ^  al. (1975) have shown that ^  vitro CS treat­
ment of human mononuclear phagocytic cells inhibited both IgG and 
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complement receptor activity of the phagocytic cell membrane. This 
important immune mechanism was depressed at drug dosage levels that had 
no inhibitory effect upon the ability of the monocyte to phagocytize 
latex and neutral red particles. 
Delayed-Type Hypersensitivity to Specific Antigens 
Bosman and Feldman (1970) reviewed the cellular events that occur 
in the pathogenesis of delayed-type hypersensitivity (DTH) reactions 
following the intradermal injection of antigen to which the host had 
been sensitized. In the same report they summarize their own investi­
gations into the composition, morphology and source of cells in skin 
reactive tissue in sensitized rats. A reasonably rational brief descrip­
tion of the cellular response to DTH reactions can be formulated from 
this report as follows; First, at the site of injection of the sensi­
tizing antigen a relatively small number of antigen specific T lympho­
cytes accumulate, react with the specific protein, and produce a number 
of inflammatory reagents. Three principal factors involved in the 
continued DTH response appear to be macrophage chemotactic factor (MCF), 
macrophage inhibitory factor (MIF), cytotoxins, and permeability factor. 
The combined action of MCF and MIF directs the subsequent site accumula­
tion of nonspecific bone marrow-derived macrophages from the adjoining 
arterioles and capillaries. The 24-48 reaction is predominantly of the 
monocyte/macrophage moiety (approximately 80%). 
DTH reactions to intradermal injections of viral antigens have 
been demonstrated following herpesvirus infections in man (Nagler 1944; 
Nagler 1946; Rose and Malloy 1947), chickens (Dawe et al. 1971), pigs 
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(Skoda ^  al. 1968; Yotov 1973; Smith and Mengeling 1977), and cattle 
(Darcel and Doward 1972; Girdn et al. 1975). Both reports of the use 
of skin test in IBRV infected cattle indicate that not all animals 
with serum virus-neutralizing antibodies responded with a positive 
reaction and that one animal in an infected group of cattle repeatedly 
tested negative to SNV but was posibive to the DTH response (Girôn £t al. 
1975). 
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MATERIALS AND METHODS 
Cell Cultures 
Embryonic bovine turbinate (EBT) cells 
Primary cell cultures were prepared from the surface epithelial 
tissues of the turbinates of fetal calves following the basic procedures 
of McClurkin £t al. (1974). Modifications included the use of only 
surface epithelial tissue and the use of Hank's balanced salt solution 
(HBSS) to replace PBS in the initial culture preparation. Metabolic 
depression, degenerative changes and support of viral replication seemed 
to be inhibited in 37th to 45th passage levels; therefore, new primary 
cells were prepared when these levels were reached. Each new primary 
cell culture and second and subsequent random passage levels were tested 
for indigenous bovine viral diarrhea (BVD) virus and mycoplasmas; only 
those found to be free were maintained. Cell stocks were maintained in 
2 1 75 cm plastic flasks and transferred at a 1:2 ratio from 1 to 6 week 
intervals depending upon the need for cells. Routine weekly supplies were 
prepared by Central Services, National Animal Disease Center (NADC), 
Ames, Iowa. 
Embryonic bovine kidney (EBK) cells 
EBK cells were prepared in a manner similar to that described for 
EBT cells and were used only initially in passage of viral stocks and to 
prepare exposure viral suspensions for experiment 2, 
^Falcon Plastics, Inc., Oxnard, CA. 
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Colostrum-deprived isolation reared (CDIR) calves 
Except for cattle in experiment 1, all experimental cattle were 
CDIR calves. They were obtained from commercial farms by the Animal 
Supply Section, NADC, and hand-reared in isolation by a modification of 
the technique reported by Edward e^ (1967). Modifications of the 
technique included keeping all calves deep-bedded on fir shavings under 
heat lamps for the first week of life and a feeding schedule of 4 times 
each day of dried milk replacer with antibiotics.^ 
The supplier's recommendations were followed on the daily amount of 
dried milk replacer but approximately one-half the recommended daily 
amount of water was used for reconstitution. All calves were fed 4 
times each day at approximately 8 hour intervals for the first week 
and gradually changed to 3 then 2 feedings at 8:00 AM and 4:00 PM at 
2 weeks of age. Reconstituted milk replacer was fed from hand-held 
2 plastic nippled bottles that were cleaned and immersed in 0.1% Roccal 
solution between feedings. First-day-of-life blood samples were taken 
and serum was separated from clotted blood and tested for IBRV antibodies. 
Conventional cattle 
Eleven feeder steers approximately 11 months of age that had been 
raised in the conventional manner in commercial herds, were used in 
experiment 1. They had been purchased by the Animal Supply Section, 
NADC, from herds that were free of IBRV antibodies. 
^Land 0' Lakes Creameries, Minneapolis, MN. 
2 Alkyl dimethyl ammonium chloride. National Laboratories, Montvale, NJ. 
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Virus Strains and Virological Techniques 
Seed stock and IBRV working-stock pools were prepared in large 
batches from infected EBK and EBT cell monolayers that had been tested 
and found free of BVD and mycoplasmas. Pools were divided into small 
aliquots and stored frozen at -90 C until ready to be used. Aliquots 
of the pool were titrated immediately after preparation and during each 
major incident when the stock was used. 
IBRV-Colo strain 
This IBRV strain was obtained, as a reference seed stock virus, 
from Dr. T. W. Tamoglia, USDA, Veterinary Services Biologies Laboratory, 
Large Animal Viral Products Section, Ames, Iowa. He had received the 
strain from Dr. T. L. Chow, Colorado State University, Fort Collins, 
Colorado, who stated that it was an isolate of bovine respiratory disease 
origin that had been passed 5 times in embryonic bovine kidney (EBK) 
cells. Dr. Tamoglia passed the isolate once in EBK cells, exposed a 
nonimmune calf intranasally, and prepared the seed stock from primary 
EBK cells inoculated with nasal secretions collected 10 days post 
inoculation. The seed stock virus was passed 2 times in primary EBK 
cells in our laboratory for exposure pools of virus (Experiment 1) or 
continued 1-3 additional passages in EBT cells for all other experiments. 
All cells used for passage and virus pool production were free from BVDV 
and mycoplasmas. 
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IBRV-LA strain 
The LA (Los Angeles) strain of IBRV was obtained from the American 
Type Culture Collection (ATCC No. VR 188) Rockville, Maryland. The 
isolate was passed 2 times in EBK cells for exposure pools of virus. 
IBRV-K22 strain 
The K22 strain (Potgieter and Mare 1974) IBRV was obtained from 
Dr. L. Potgieter, Department of Microbiology and Preventive Medicine, 
College of Veterinary Medicine, Iowa State University, Ames, Iowa. It 
was a strain received from Dr. D. G. McKercher, School of Veterinary 
Medicine, Davis, California. The strain was isolated from a clinical case 
of infectious pustular vulvovaginitis and has been passed approximately 
28 times in bovine cell cultures. It had been plaque purified 3 times and 
passed 9 times in Madin-Darby bovine kidney cells (MDBK:21) when we 
received the seed stock. The stock pool (exposure virus suspension. 
Experiment 4) was prepared from first seed stock passage EBT cells. The 
titer of this virus pool was 1.0 x 10 pfu/ml of suspension. 
IBRV-Jensal strain 
The Jensal strain (Potgieter and Mare 1974) was a modified live virus 
vaccine strain. The seed stock virus pool was prepared from a commercial 
vaccine^ by Dr. Potgieter in the 3rd passage in MDBK:21 cells. The stock 
pool (exposure virus suspension. Experiment 4) was prepared from first 
seed stock passage in EBT cells. The titer of this virus pool was 1.2 
8 2 X 10 ' pfu/ml of suspension. 
Jensen-Salisbury Laboratories, Kansas City, MO. 
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Virus isolation techniques 
Nasal swabs were taken from cattle only after cleaning of the 
anterior nares. Cotton-tipped applicators were inserted approximately 
6 inches into the doc&l meatus of the nasal passage, removed and placed 
into 2.5 ml of pre-cooled MEM containing 4X antibiotics and mycostatin. 
The samples were agitated, stored frozen at -90 C until tested, or the 
nasal swabs expressed of absorbed fluids, the tubes were centrifuged at 
600 Xg for 20 min and 0.1 ml of the supernatant fluid placed on each of 
3 monolayer cultures of EST cells and observed daily for 10 days for the 
development of viral-induced CPE. Cell cultures with CPE typical of IBR 
were harvested by freezing within 24 hours of the initial observance of 
CPE. Cultures without obvious CPE were passed onto new monolayer 
cultures after 10 days of incubation. Two such passages were made and 
observed for 10 days each before a final negative result was recorded. 
Selected positive samples (those with typical CPE) from each experiment 
were identified as IBRV by serological methods. 
Tissue samples from experimental animals taken during postmortem 
examination were minced, ground in a Tenbroeck tissue grinder, and 
prepared to a 20% suspension in MEM containing antibiotics and 
mycostatin. One-tenth ml of the supernatant fluid was removed 
and placed into each of 3 monolayer EBT cultures. The samples were 
handled in the same manner as described above for nasal swab samples. 
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Immunological Methods 
Serological tests to quantitate the amount of viral antibody in 
a serum sample and to identify viral isolates essentially as described 
by Lennette and Schmidt (1969) were used in these studies. Fluorescent 
antibody procedures (Brown e^ £l. 1968) for the identification of IBRV 
in infected tissues were used occasionally. 
Serum-virus neutralization (SVN) 
Serum neutralization of viral plaque reduction was used to quanti­
tate IBRV antibody in serum samples. Tests were performed in EST cells. 
2 
Confluent monolayer cultures of EBT cells were prepared in either 75 cm 
plastic flasks or 60 mm plastic Petri dishes^. Cultures were incubated 
at 35 C and Petri dishes were kept in a 5% CO^ humidified chamber. 
2 
Overlay media was prepared by dissolving 7.0 gm Ion agar 2S in 857 ml of 
boiling distilled water then cooled to 44 C in a water bath. The following 
reagents were then added to the 44 C agar: (1) 97 ml of lOX minimum 
3 
essential medium (MEM), Eagle, with Earle's salts, (2) 30 ml heat inac­
tivated (56 C for 30 min) fetal calf serum, (3) 14 ml 7.5% NaCHO^ in H^O, 
(4) 5 mg Gentocin^ (1 ml), and (5) 35 units Mycostatin^/ml. The mixture 
1 Falcon Plastics, Inc., Oxnard, CA. 
2 Colab Laboratories, Glenwood, IL. 
3 Grand Island Biological Compound, Grand Island, NY. 
4 Gentamicin sulfate, Schering Corp., Kenilworth, NJ. 
^Nystatin, E. R. Squibb and Sons, Inc., New York, NY. 
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was allowed to remain at 44 C until dispensed (within 1 hr) in 5 ml 
amounts as an agar overlay. 
Virus-challenge stock pool aliquots were diluted in MEM containing 
5% guinea pig serum (complement) to give approximately 100 plaque 
forming units/0.1 ml. Sera to be tested were heat inactivated at 56 C 
for 30 min. and 2-fold dilutions (1:2 through 1:256 routinely) were 
prepared in MEM. A test control negative and a test control positive 
serum of known antibody titer were included in each group of serum to 
be tested. Equal amounts of the challenge virus-complement suspension 
and the appropriate serum dilutions were mixed and allowed to react 
overnight at 4 C. The reaction was continued for 1 hr at room temperature 
prior to placing the mixture on cell monolayers. Medium was removed 
from cell culture monolayers and 0.2 ml of each serum-virus mixture was 
added to each of 3 monolayer cultures. The mixture was adsorbed to 
the cell monolayer for 90 min at 35 C in a humid, 5% CO^ atmosphere. 
During the adsorption period the Petri plates were agitated every 15-20 
min to redistribute the suspension. Following the adsorption period 
the monolayer was rinsed with 4 ml of MEM and 5 ml of the liquid (warmed) 
freshly prepared agar was added to each dish and allowed to cool to room 
temperature, inverted and incubated for 5-7 days before plaques were 
counted. Agar overlay was gently removed from monolayer cultures; 
they were stained for 2-3 minutes with a 1% crystal violet tincture of 
20% ethyl alcohol. Plaques were counted and the antibody titer was 
recorded as the reciprocal of the seri-m dilution that had neutralized 
50% or more of the plaques when compared to the negative serum control. 
39 
Whole blood cultures 
The whole blood culture techniques of Park and Good (1972) as 
modified by Johnson and Muscoplat (1973) were further modified by in­
creasing the volume of whole blood cultured to 0.25 ml amounts diluted 
with 0.25 ml of RPMI-1640^ medium containing 15% fetal calf serum. 
Further modifications included the lengthening of the prelabeling 
incubation period to 48 hours, and the adaptation of a more convenient 
harvesting method with the apparatus described below. 
Whole blood cultures were prepared as follows: 0.25 ml of venous 
heparinized blood was mixed with 0.25 ml of RPMI-1640 containing 15% fetal 
calf serum. Duplicate cultures were prepared for each mitogen dilution 
or specific immunostimulant dilution. Duplicate control cultures con­
taining cell control antigen and RPMI-1640 only were also prepared from 
each blood sample. Preselected dilutions of phytohemagglutinin-M (PHA-M), 
specific viral mitogens (IBRV-Ag) and cell control antigens were added 
in 50 yl amounts to each culture at the time of set-up. The cultures 
were incubated in a humidified CO^ incubator at 37 C for 48 hours and 
3 2 then pulsed with 1.0 uci of HdT and the incubation continued for 
another 14 hours. The initial efforts to conduct whole blood cultures 
following the methods of Good and Campbell (1948) and Johnson and Muscoplat 
(1973) gave erratic results because of the numerous cumbersome techniques 
^Roswell Park Memorial Institute Medium #1640, Grand Island 
Biological Co., Grand Island, NY. 
2 3 
Thymidine (Methyl H) 6.7 Ci/M mole, New England Nuclear Co., 
Boston, MA. 
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of the harvesting procedures; therefore, a method for harvesting was 
developed whereby whole blood could be harvested by lysing erythrocytes 
with distilled water and using glass fiber filters^ to retain DNA of 
the stimulated cells in culture. Microsized filters and equipment used in 
the Otto-Heller cell precipitator/harvester could not be used because the 
debris in the large volume whole blood cultures rapidly clogged all 
filter pores. A manifold-type multiple macrosized filter apparatus was 
designed (Figs. 1 and 2). The fabrication was completed by the Plastic 
Shop of the Equipment and Preventive Maintenance Section, NADC. The 
body of the apparatus was constructed to two solid blocks of plastic 
(25 cm X 10 cm X 10 cm and 25 cm x 10 cm x 5 cm). Conical wells 2.5 cm 
in diameter at the base were drilled 2.0 cm apart and filled with a 
2 filter base support taken from a SX 2500 Milipore filter (see Fig. 2). 
Effluent holes were drilled to connect from each filter and fitted to 
connect to a vacuum line. Matching holes were drilled in the top block 
and fitted with plastic syringe barrels. Grooves were constructed in 
the bottom part of the top block to seat a 2.50 cm diameter rubber "0" 
ring (Fig. 2). Metal clamps (Fig. 1) were affixed to secure the blocks 
together in an air tight fashion. During harvesting the effluent tube 
was fastened to a vacuum line and distilled water-lysed cultures poured 
into plastic syringe barrels and washed with 40-50 volumes of distilled 
water. Twelve cultures could be harvested before the manifold was dis­
assembled, filters removed and replaced with new filters for the next 
^Glass Fiber Filter, 934AH, Reeve Angel Co., Clifton, NJ. 
2 
Millipore Corp., Bedford, MA. 
Figure 1. A manifold-type multiple macrosized filter apparatus 
designed to harvest whole blood cultures. 
Notice locking clamps and 6 plastic syringe barrels 
in position for harvesting. Six other adapters are 
available. 
Figure 2. Whole blood culture harvester opened to demonstrate 
rubber "0" ring seal and filter base (arrows). 
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culture. The filter discs were placed into scintillation counting vials 
and dried overnight. The following morning each scintillation counting 
vial containing the disc was filled with 10 ml of POPOP scintillation 
counting fluid and the amount of radioactivity determined by counting 
in a Model 3380 Packard scintillation counter^. The stimulation index 
was calculated by dividing the average counts per minute of 2 IBRV-Ag or 
PHA-M stimulated cultures by the average counts per minute in 2 control 
cultures that had been mock stimulated with a control antigen prepared 
from noninfected EBT cells by the same method used to prepare the IBRV-Ag. 
Isolated lymphocyte microcultures 
Blood was collected by venipuncture of the jugular vein and Immediately 
placed into tubes containing 50 USP units of heparin per ml of blood. 
Heparinized blood was diluted 1:4 in physiological saline (1 part blood, 
3 parts saline) mixed thoroughly and 10 ml was carefully layered over 
4.0 ml of Ficoll-Hypaque solution. The suspension was centrifuged at 
400 Xg for 30 min at room temperature. The banded layer of lymphocytes 
was removed, resuspended (washed) in 20 volumes of HBSS and centrifuged 
at 250 Xg for 30 min at room temperature. The supernatant was removed, 
the washing step repeated and the cells were suspended in a small amount 
of RPMI-1640 medium containing 15% homologous serum. The cell suspension 
2 
was counted in a Model 75 Sanborn Fronmer cell counter and diluted to a 
final concentration of 2.0 x 10^ cells per ml in RPMI-1640 containing 15% 
^Packard Instrument Co., Downers Grove, IL. 
2 Sanborn Co., Waltham, MA. 
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homologous serum and 100 units of penicillin in 100 mg streptomycin per 
ml of medium. The cultures were prepared in flat-bottomed, 96-well micro-
filter-type tissue culture plates^. Appropriate numbers of microtiter 
plate wells were filled with 0.15 ml of the cell suspension from each 
animal. Desired amounts of each mitogenic stimulant were added to 
triplicate cultures. The plate was incubated at 37 C in a humidified 
5% CO2 atmosphere. Following 50 hours of incubation each culture was 
pulsed with 0.25 yci of ^HdT in 0.05 ml RPMI-1640 and the incubation 
3 
continued for 20 hours. Initially 1.0 yci of HdT per culture was used; 
later it was found that 0.25 yci was just as effective. Cultures were 
harvested from the plates with an Otto Hiller cell precipitator/harvester, 
2 Model A , that lysed the cultures with distilled water and deposited the 
prcipitate on glass fiber filter paper that retains DNA molecules. The 
filter papers were dried overnight in scintillation counting vials filled 
with 10 ml of POPOP scintillation counting fluid and the radioactivity 
counted on a Packard scintillation counter. The stimulation index was 
calculated by dividing the average counts per minute of 3 stimulated 
cultures by the average counts per minute in 3 control cultures that had 
been mock stimulated with a control antigen prepared from noninfected 
EBT cells by the same method used to prepare the IBRV-Ag. 
^Falcon Plastics, Inc., Oxnard, CA. 
2 Otto Hiller Co., Madison, WI. 
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Determination of ^  cell - 2 cell percentages 
Lymphocytes were harvested and separated by the same technique de­
scribed for isolated lymphocyte microcultures. Suspensions were prepared 
containing 4.0 x 10^ cells/ml in HBSS and 0.1 ml of this suspension was 
incubated with. 0.2 ml of a 1:30 dilution of anti-bovine globulin rabbit 
serum conjugated with fluorescein isothiocyanate^. The mixture was 
incubated at room temperature for 30 min with occasional gentle mixing. 
The cells were then washed 2 times with 5 ml of HBSS containing 0.1% 
sodium azide. After the second centrifugation slides were prepared with 
1 drop of cell suspension, coverslipped and ringed with glycerine. Two 
hundred cells were counted using reflected fluorescent microscopy and 
phase contrast microscopy simultaneously. Cells having evidence of 
specifically stained immunoglobulins on their surfaces were enumerated 
as B lymphocytes whereas all other mononuclear cells in the same size 
range were considered to be T lymphocytes. 
Preparation of Ficoll-Hypaque solution 
2 Ten gm of Ficoll 400 (high mol. wgt. dextran 400,000) was dissolved 
in 100 ml distilled wacer by low temperature heating and vigorous stirring 
^Fluorescein-isothiocyanate-conjugated antibovine globulin rabbit 
serum was provided by Dr. George M. Brown, APHIS-Virological Reagents 
Section, who had prepared the antiglobulin in rabbits by repeated injec­
tions of bovine globulin supplied to him by Dr. M. Kaeberle, Iowa State 
University, Ames, Iowa. 
2 Pharmacia Fine Chemicals, Piscataway, NJ. 
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(Solution A). Solution B was prepared by mixing 20 ml of 50% hypaque 
sodium^ in 9.4 ml of distilled water; 29.4 ml of Solution B was then 
mixed with 53.33 ml of Solution A and the specific gravity carefully 
adjusted to 1.080. The mixture was then sterilized by filtration through 
an Amicon filter (Model 402, XM-50)^. 
Preparation of POPOP scintillation counting fluid 
Five grams of PPG and 0.3 grams of Ortho-l-methyl POPOP were dis­
solved in 1,000 ml of toluene. The preparation was stored in colored 
bottles at 4 C until used. 
IBRV antigen and cell control antigen preparation for skin testing, 
lymphocyte microculture and whole blood immunostimulation 
IBRV antigen was prepared by inoculating monolayer EBT cell cultures 
with IBRV (1.0 - 2.0 ml of 1.0 x 10^'^ pfu/ml). Cells were harvested by 
two rapid freeze-thaw cycles when maximal viral CPE was observed, usually 
48 hours post infection. Stock preparations with titers less than 1.0 x 
Q n 
10 • pfu/ml were discarded. The cell suspension was sonicated for 20 
seconds with a Branson sonifier and centrifuged at 400 Xg to remove 
large particle cell debris. The supernatant suspension was then con­
centrated 50 to 100 X by filtration through an Amicon X-M 50 filter. The 
IBRV suspension was heat-inactivated for 2 hours at 56 C. Aliquots were 
^Winthrop Laboratories, New York, NY. 
2 Amicon Corp., Lexington, MA. 
•7 
Packard Instrument Co., Downers Grove, IL. 
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inoculated onto EBT cell monolayers and passed three times to assure 
that all IBRV had been inactivated. Control cell antigens were pre­
pared from noninfected cells from the same lot of EBT cells each time 
and an antigen was prepared. 
Exposure of cattle to IBRV 
All cattle except those in experiment 2 were exposed to IBRV by the 
aerosol route. The method described by Sinclair and Tamoglia (1972) was 
used in all other initial and challenge exposures. All animal contact 
parts used to expose each animal had been sterilized prior to the inocu­
lation procedure. Cattle in experiment 2 were exposed to IBRV by the 
aerosol route by nebulizing IBRV suspensions with a Collison generator 
through a Henderson tube apparatus (Beard and Easterday 1965). 
Histopathology 
Selected tissues, 3.0 x 5.0 cm or smaller, were taken from cattle 
during postmortem examination or by surgical biopsy, fixed overnight in 
10% formalin buffered with calcium phosphate, processed by dehydration in 
graded ethanol and infiltrated and embedded in commercial paraffin using 
an autotechnicon^. Embedded tissues were sectioned at 6.0 u and stained 
with hematoxylin-eosin (H&E) and Giemsa stains. 
Experimental Design 
Experiment ^  
Eleven 600 to 800 pound Holstein crossbred feeder steers approximate­
ly 1 year of age were used in experiment 1. They were fed a growing ration 
^Technicon Corporation, Tarrytown, NY. 
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composed of ground corn mixed with soybean meal and free choice good 
quality alfalfa hay. They were maintained in an area isolated from other 
cattle. All had been used in a vaccine trial experiment and had been 
challenged by intranasal exposure 90 days previously with 4.0 ml of a 
virus suspension containing 10^ '^  TCID^ Q of IBRV (McKercher isolate) in 
its 8th cell culture passage. Following challenge all animals had 
developed hyperthermia, necrotic nasal plaques, and had shed virus in 
their nasal secretions for 8-12 consecutive days beginning 1-2 days after 
challenge. (The animals were made available following the vaccine trial 
conducted by Dr. T. W. Tamoglia.) The steers were divided into 3 groups 
based upon their previous history of vaccination, IBRV challenge and 
serological response. Group I consisted of 4 steers treated with 30 mg of 
dexamethasone^  intravenously for 5 consecutive days. Group II contained 
4 steers injected subcutaneously with 10 ml of a 1:1000 solution of 
2 
epinephrine for 5 consecutive days. Group III was composed of 3 
animals used as controls. 
Each steer was examined for clinical signs of respiratory disease. 
Rectal temperatures were recorded, nasal swabs were taken for viral 
isolation and blood samples were drawn for total leukocyte determinations 
each day for 10 days from the beginning of the drug treatments. One 
animal (#3031) was killed and necropsied on the 8th day post treatment. 
This experiment was begun in November of 1972 and was designed to determine 
A^zium, Schering Corp., Kenilworth, NJ. 
2 Haver-Lockhart Laboratories, Shawnee, KA. 
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if corticosteroids (CS) could be used to cause recrudescence of IBRV 
infections in previously exposed feedlot steers. 
Experiment 2^  
This experiment was conducted to determine the effect of dexamethasone 
treatment on acute IBRV infections. Four 8-week-old CDIR calves were 
used in the experiment. Two calves (#7222 and #7255) were treated for 
5 days with 15 mg of dexamethasone administered intravenously. They were 
subsequently inoculated intranasally fay atomizing 2.5 ml of an IBRV 
8 2 
suspension containing 1.0 x 10 ' pfu/ml. Each animal was also given 
5.0 ml of the same IBRV suspension by intratracheal (IT) injection by 
inserting a 20 gage l^ j inch needle between tracheal rings in the mid-
tracheal area. Prior to IT inoculation the skin of the injection site 
was clipped free of hair and disinfected with ethyl alcohol. Following 
IBRV exposure, dexamethasone dosage was increased to 20 mg daily. Two 
calves (#7228 and #7256) not treated with dexamethasone served as acute 
IBRV infected controls. These 2 animals were exposed to the same 
amount of virus by the same method. Nasal swabs for viral isolation, 
heparinized blood samples for clinical hematology, and rectal temperatures 
were taken daily. Postmortem examinations were conducted on calves that 
died as a result of the disease or that were killed 17 days after initial 
IBRV exposure. Tissues and organs were exposed and separate sets of 
sterile instruments used to take tissue samples for viral isolation and 
histological examination. 
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Experiment 2 
Ten CDIR Holstein and Holstein-cross cattle approximately 6 months 
old were used in this experiment. The experiment was designed to deter­
mine the nature of corticosteroid-induced recrudescence in cattle 
experimentally exposed to low doses of IBRV and to compare the effect 
of 2 virus strains (IBRV-Colo and IBRV-LA) in recurrent infections. 
Cattle in group I (4 animals) were exposed to aerosols of IBRV-Colo 
(titer 10^ '^  pfu/ml) generated in a modified Henderson tube by a 
Collison nebulizer that produced droplets averaging 2 y in diameter. 
Cattle in group II were exposed to approximately the same amount of 
IBRV-LA by the same technique. Group III (2 animals) served as controls 
on initial exposure. All animals including controls were challenged 
8 3 
with IBRV-Colo strain at a higher dosage rate (titer 10 ' pfu/ml) by 
the same exposure method 2^  months after initial exposure. All cattle 
were skin tested for DTH response to inactivated IBRV antigen 4 months 
after challenge exposure. Areas were clipped free of hair on the neck and 
0.1 ml amounts of the antigen were injected intradermally on the neck 
and caudal fold. Cell control antigen was injected on the opposite side. 
Sites were evaluated at 24 and 48 hours post injection. 
Six months after challenge exposure all animals were skin tested 
again and injected intravenously with dexamethasone for 10 consecutive 
days. Blood samples were drawn at 1, 2, 4, 8, 12, 24, 48, 72, 96 hours 
and 7, 4, and 28 days after the initial injection to determine the 
leukocyte response to corticosteroids and also to evaluate the biochemical 
changes in plasma in response to corticosteroid injection. Nasal swabs 
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were taken for viral isolation attempts daily for 15 days and serum, 
samples for anti-IBRV antibody evaluations were taken on a weekly basis. 
At the end of the 10-day treatment period, the skin test response was 
evaluated following corticosteroid treatment. One year after initial 
IBRV exposure, the microculture isolated lymphocyte technique was adapted 
for use in cell-mediated immunity studies and a series of studies was 
begun on these cattle. Base line determinations for blastogenic responses 
of lymphocyte cultures of these cattle to PHA-M and inactivated IBRV and 
control antigens were conducted, Dexamethasone treatment by the intra­
venous route (30 mg/animal) was instituted and its effect on the lymphocyte 
blastogenic response was evaluated. It became necessary during dexa­
methasone treatment to process (by the Ficoll-Hypaque technique) 
approximately 8-10 times the amount of blood used previously in order 
to harvest the required amount of lymphocyte to complete the tests. 
Total leukocyte counts, virus shedding, B lymphocyte - T lymphocyte 
ratios and IBRV antibody responses were determined following dexametha­
sone treatment. 
Finally, 2 of these cattle were used to evaluate the cellular 
inflammatory infiltrate in response to the intradermal skin test and 
to evaluate the changes induced due to dexamethasone treatment. Surgical 
biopsies were taken of the skin test site 12, 24, 48 and 72 hours after 
intradermal injection. Dexamethasone treatment (20 mg I.V.) was again 
instituted for 10 days and the intradermal skin test was again adminis­
tered in 6 different sites on the neck. Surgical biopsies were taken 
at 12, 24, 48, and 72 hours after intradermal injection of the inactivated 
IBRV antigen. 
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Experiment ^  
The objective of experiment 4 was to determine the potential of 
using specific antigen-induced blastogenesis of isolated lymphocyte 
microcultures and DTH skin testing to differentiate strains of IBRV 
and to compare the pathogenicity of a vaccine strain (Jensal), IPV 
(K-22), and IBRV-Colo for cattle exposed intranasally to similar doses 
of these agents. An additional objective was to evaluate the effective­
ness of dexamethasone to cause IBRV recrudescence in cattle exposed to 
modified live virus vaccine strains of IBRV. 
Six, 6-month-old calves were divided into 3 groups of 2 calves 
each and held in separate quarters during the entire experiment. Two 
calves each were exposed intranasally to similar doses of Jensal 
(modified live virus vaccine), K-22 (IPV), and Colo (field strain) 
of IBRV. 
During the acute infection isolated lymphocyte microcultures were 
exposed to homologous and heterologous inactivated IBRV antigens and 
their blastogenic response evaluated. Six weeks after initial exposure 
all animals were skin-tested with homologous and heterologous strain 
antigens and the DTH response evaluated. Finally, 6 months post exposure 
all 6 calves were treated for 10 days with dexamethasone and during this 
time nasal swabs for viral isolation and blood samples for lymphocyte 
microculture were collected, prepared and evaluated. 
Experiment 5^ 
This experiment was designed to compare the effectiveness of 
whole blood cultures and isolated lymphocyte cultures to detect 
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the development of T lymphocyte sensitization during a long term 
chronic infection and to compare the results of immunosuppression with 
dexamethasone to that induced with cyclophosphamide treatment. Base 
line blastogenic response studies were conducted on 6 non-IBRV immune 
6-month-old calves and 2 calves (positive controls) chronically infected 
with IBRV. All calves were exposed to IBRV by intranasal instillation. 
Blastogenic responses to PHA-M and inactivated IBRV antigen were con­
ducted every other day for 2 weeks; then at 1-week intervals for 4 weeks 
and intermittently for 1 year. One year from the initial exposure 3 
calves were treated with dexamethasone (Table 13) and 3 calves were 
treated with cyclophosphamide for 10 days. Cyclophosphamide was adminis­
tered intravenously at the approximate rate of 4 mg/kg of body weight 
for the first 4 days and 2 mg/kg of body weight for the next 5 days. 
Nasal swabs for viral isolation were taken daily. Whole blood cultures 
and isolated lymphocyte microcultures were prepared every other day at 
12-18 hours following immunosuppressive treatment. All animals except 
the positive controls were killed 10 days following the beginning of 
dexamethasone or cyclophosphamide treatment. Postmortem examinations 
were conducted and tissues were taken for viral isolation and histo-
pathological examinations. Clinical hematological values were determined 
on each animal at the time blood cultures were established and B cell -
T cell ratios of isolated lymphocyte suspensions were determined through­
out the treatment period. 
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RESULTS 
Results of each experiment are presented in the following tabular or 
narrative form as they relate to the objectives of the experimental design. 
Experiment 1^ . 
All steers in group I (dexamethasone treated group) began secreting 
IBRV in their nasal mucus on day 4 or 7 after dexamethasone treatment and 
continued to secrete virus until 8 days post treatment (Table 1). All 
four animals developed necrotic nasal mucosal plaques (Figs. 3 & 4) 
by 4 days post treatment and plaques were present for at least 1 week 
following the initial observation. The animal (#3031) that was killed 
and necropsied on day 8 had extensive mucosal plaques in the nasal 
mucosa and turbinates (Figs. 5 & 6). There were also necrotic plaques 
on the epiglottis (Fig. 7) and larynx. The suprapharyngeal lymph nodes 
were swollen, edematous and contained numerous petechial hemorrhages. The 
examination of H&E stained thin sections revealed numerous small foci 
of necrotic ulceration of the squamous epithelium of the Internal nares, 
turbinates, epiglottis and larynx. Ulcers were covered by fibrins-con­
taining neutrophils and cellular debris (Fig. 8), and the surrounding 
tissues were heavily infiltrated with neutrophils, lymphocytes and 
macrophages (Fig. 9). Necrotic mucosal plaques appeared histologically 
as large pedunculated, mushroom-shaped masses arising abruptly from the 
lesion interrupted stratified squamous epithelium (Fig. 10). These masses 
contained fibrin, necrotic inflammatory and epithelial cells, and a few 
scattered fibroblasts. Multifocal areas of ballooning degeneration were 
observed in the epithelium of the upper respiratory tract especially at 
the periphery of the necrotic plaques. Degenerating stratified squamous 
epithelium at the edge of the plaques contained eosinophilic intranuclear 
inclusion bodies (Figs. 11 & 12). Deep within the submucosa there were a 
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Table 1. Clinical, serological and virological evidence of IBRV 
recrudescence in cattle following dexamethasone and epinephrine 
treatment 90 days after experimental IBRV exposure. 
Animal Virus Antibody 
Number Treatment Isolation Lesions^  Pre Post 
3031 DEX^  4, 7-8= Yes 16^  ND® 
5859 DEX 7-8 Yes 64 256 
5253 DEX 7-8 Yes 32 512 
7071 DEX 7-8 Yes 16 512 
3637 
f 
EPI None No 16 32 
4547 EPI None No 32 32 
6061 EPI None No 16 16 
100 EPI None No 64 32 
5455 None None No 64 64 
2829 None 7 No 32 16 
6465 None None No 16 16 
N^ecrotic nasal mucosal plaques observed. 
D^examethasone (Azium) 30 mg. daily for 5 days. 
D^ays post treatment on which IBRV isolated from nasal secretions. 
R^eciprocal of serum dilution neutralizing 50% of plaques in SVN 
test. Pretreatment sample was taken on day treatment was begun and 
post treatment samples taken 14 days post treatment. 
Q 
Not determined. 
E^pinephrine, 1:1000, 10 ml daily for 5 days. 
Figure 3. Necrotic nasal mucosal plaques that appeared on the nasal 
septum of a steer 4 days after dexamethasone treatment was 
begun. 
IBRV virus was isolated from the nasal secretions the 
same day these plaques were first observed. 
Figure 4. Close-up view of nasal mucosal plaque. 
Notice raised appearance of the lesion. 
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Figure 5. Raised necrotic mucosal plaques observed during 
postmortem examination of steer killed 8 days 
after dexamethasone treatment began. 
Figure 6. Necrotic mucosal plaques observed on turbinates during 
postmortem examination of steer killed 8 days post 
dexamethasone treatment. 
Notice multiple small papules. 

Figure 7. Epithelial ulceration and necrosis of epiglottis and 
larynx observed during postmortem examination of steer 
killed 8 days post dexamethasone treatment. 

Figure 8. Tissue section of nasal mucosa from steer killed 8 days 
after dexamethasone treatment. 
Edge of necrotic ulcer appears at lower right. Fibrin 
mass containing neutrophils and necrotic cellular debris 
covers ulcer and adjacent stratified squamous epithelium. 
Notice inflammatory cells in submucosal area. Hematoxylin 
and eosin stain. 
Figure 9. Lymphocyte, macrophage and neutrophil accumulation in the 
submucosa of nasal tissue of a steer killed 8 days after 
dexamethasone treatment. 
Hematoxylin and eosin stain. 

Figure 10. Section of tissue from pedunculated nasal mucosal plaque 
following dexamethasone-induced IBRV recrudescence. 
Notice abrupt interruption of stratified squamous 
epithelium and infiltration of the submucosa with 
inflammatory cells. Hematoxylin and eosin stain. 

Figure 11. Ballooning degeneration of the stratified squamous 
epithelium at the periphery of necrotic plaque in nasal 
mucosa of calf following dexamethasone-induced IBRV 
recrudescence. 
Note intranuclear inclusion bodies at arrows. 
Hematoxylin and eosin stain. 
Figure 12. Large intranuclear inclusion body in a stratified squamous 
epithelial cell at periphery of necrotic plaque in nasal 
mucosa of a steer killed 8 days after dexamethasone treat­
ment. 
Hematoxylin and eosin stain. 
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few vessels with perivascular accumulations of plasmacytes and lympho­
cytes. Sub-epithelial tissues in these areas contained multiple foci of 
mononuclear cells, principally lymphocytes (Fig. 13). 
Histopathological examination of the lymphatic tissue associated 
with the respiratory tract revealed diffuse necrosis of lymphoid cells 
and reticuloendothelial hyperplasia especially in the paracortical and 
follicular areas. 
Frozen sections of necrotic mucosal plaques stained with anti-IBRV 
fluorescein-conjugated antibody preparations had intensive staining at 
the periphery of the lesions of the nasal septum and epiglottis (Fig. 14). 
Similar sections of the bronchial nodes were also positive for IBRV 
antigen (Fig. 15). 
Even though virus was isolated from the nasal mucus taken the day 
before the animal was killed, 2 attempts to isolate virus from the 
nasal septum, larynx, bronchial and other regional lymph nodes were not 
successful. 
All animals treated with dexamethasone had increased circulating 
anti-IBRV antibodies in serum samples taken 2 weeks after treatment 
(Table 1). 
There were no viral isolations from daily nasal mucus samples taken 
from epinephrine treated or control animals except from 1 control animal 
(#2829) 7 days after other cattle had been treated (Table 1). No nasal 
mucosal plaques were observed and there were no increases in antibody 
titers in these 2 groups. 
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Experiment 2^ 
The two 2-month-old calves infected with IBRV not treated with 
dexamethasone had mild rhinitis 1 day post exposure (DPE) and by 2 DPE 
had a high rectal temperature (Fig. 16) and distinct hyperemia of the 
mucus membranes of the nasal passages. Extensive necrosis and acute 
inflammation of the mucus membranes of the anterior nares and nasal 
septum was obvious 3 through 7 DPE. Severe respiratory distress and 
moist rales over the trachea were observed 3 to 6 DPE. These animals 
were anorectic from 3 to 5 days but showed marked clinical improvement 
at 10 DPE. Nasal lesions were healed by 14 DPE. 
Both calves treated with dexamethasone and exposed to IBRV had less 
severe disease initially than those not treated. Body temperature 
elevations were generally lower and the initial rise was delayed by 48 
hours (Fig. 16). Both calves developed severe respiratory distress 
and stenosis of nasal passages (Fig. 17) by necrotic debris often 
forced both calves to open-mouthed breathing (Fig. 18) by DPE 6. One 
calf (#7255) (Table 2) was found dying in the stall early on the 
morning of DPE 7. Postmortem and histopathological examination revealed 
extensive necrosis and severe multifocal fibrinopurulent rhinotracheitis. 
Most of the surface of the nasal turbinates was denuded of surface 
epithelium (Fig. 19). Much of the epithelium of the pharyngeal area 
was necrotic and sloughed (Fig. 20). Erosions of the ciliated epithelium 
(Fig. 21) occurred throughout the trachea. There were large areas of 
consolidation in the anterior ventral portion of all lobes of the lung 
(Fig. 22). Lymph nodes associated with the respiratory tract were 
Figure 13. Focal area of mononuclear cell infiltration in the mucosa 
and submucosa of respiratory epithelium of the larynx of a 
steer killed 8 days after dexamethasone treatment. 
Hematoxylin and eosin stain. 

Figure 14. Section of tissue adjacent to necrotic lesion of pharynx 
stained with anti-IBRV fluorescein-conjugated antibody. 
Note brightly stained area in the stratified squamous 
epithelium. 
Figure 15. Section of tissue from the bronchial lymph node of steer 
killed 8 days after dexamethasone treatment. 
Bright areas represent cells stained with anti-IBRV 
fluorescein-conjugated antibody. 

Figure 16. Rectal temperature of dexamethasone treated and nontreated 
calves exposed to IBRV by the aerosol route. 
# Daily average of two readings (A.M. and P.M.) of 
both dexamethasone treated calves. 
C>-"0 Daily average of two readings (A.M. and P.M.) of 
both nontreated calves. 
Y Exposed to IBRV. 
f 1 of 2 treated animals died. 
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Figure 17. External nares of calf with severe necrotic rhinitis 
following dexamethasone treatment and subsequent 
exposure to IBRV. 
Note narrow slit-like opening into nasal passage. 
Figure 18. Extension of head and neck and open-mouthed breathing 
by a calf following dexamethasone treatment and sub­
sequent exposure to IBRV. 
I 
't 
Figure 19. Necrosis and erosion of epithelium of turbinates in 
a calf that died 7 days after dexamethasone treatment 
and aerosol IBRV exposure. 
Figure 20. Necrosis and erosion of epithelium of the larynx and 
pharynx of calf that died 7 days after dexamethasone 
treatment and aerosol IBRV exposure. 
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Figure 21. Necrosis and erosion of tracheal epithelium of a 
calf that died 7 days after dexamethasone treatment 
and IBRV aerosol exposure. 
Figure 22. Consolidated areas of lungs of calf that died 7 days 
after dexamethasone treatment and IBRV aerosol 
exposure. 
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swollen, hemorrhagic and edematous. Ecchymotic hemorrhages were present 
on the greater omentum, mesenteric lymph nodes and the serosal surfaces 
of the caecum. Meningeal vessels were congested. Calf #7222 died 
during the night of DPE 9. Postmortem lesions were similar to those 
described for #7255 but less severe. Pulmonary consolidation was confined 
to the apical and cardiac lobes and involved much smaller areas than in 
the lungs of calf #7255. 
IBRV was isolated from nasal swabs taken from all calves on DPE 1 
and was continually recovered from daily swabs of dexamethasone-treated 
calves until their death (Table 2). Untreated calves shed virus in 
their nasal secretions until DPE 12 and virus was not recovered beyond 
that time. IBRV was recovered from all tissues taken for viral isolation 
from dexamethasone-treated calves (Table 3) but IBRV was not recovered 
from tissues taken during postmortem examination of nontreated calves 
killed DPE 17 (Table 3). 
Histopathological examination of H&E stained sections of tissues 
taken from dexamethasone-treated, IBRV-infected calves revealed extensive 
acute to subacute fibrinopurulent rhinotracheitis and necrosis of the 
nasal septum, turbinates and external nares. The lesions were charac­
terized by necrosis and sloughing of the stratified squamous epithelium, 
and infiltration of the submucosa by neutrophils and lymphocytes. 
Lymphocytes were especially prominent around small vessels and mucus 
glands. Acute to subacute laryngitis and pharyngitis characterized by 
epithelial necrosis and sloughing and the infiltration of inflammatory cells 
was present in both calves. Both treated calves had extensive tracheo­
bronchitis and acute to subacute suppurative pneumonia. Alveolar 
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Table 2. IBRV isolations from nasal swabs taken from calves infected 
by the aerosol route. Calf numbers 7222 and 7255 were treated 
with dexamethasone (15 mg/day) 5 days before and 20 mg/day 
after exposure. 
Animal Days Pre- or Post--IBRV Exposure 
Number - 1 0  1  2 3 4 5 6 7 8 9 10 12 14 16 
7222 — — + + + + + + + + 
7255 — — + + + + + ND^  
7228 — — + + + + + + + + -1- -t- + — — 
7256 — — + + + + + -t- + + + + + — — 
C^alf died of acute respiratory disease. 
C^alf died of acute respiratory disease. 
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Table 3. IBRV isolations from tissues taken during postmortem 
examinations. 
Calf Number 
Tissue 7222* 7255^  7228^  7256^  
Adrenal + ND 
Cerebrum + + 
Epiglottis + + 
Larynx + + 
Lung + + 
Mediastinal LN^  ND + 
Prescapular IN ND + 
Suprapharyngeal LN + + 
Trachea + + 
Tracheal Exudate + + 
C^alf died of acute respiratory disease 9 days after aerosol 
exposure to IBRV. 
C^alf died of acute respiratory disease 7 days after aerosol 
exposure to IBRV. 
C^alf was killed 17 days after aerosol exposure to IBRV. 
N^ot determined. 
L^ymph node. 
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macrophages and lymphocytes were also present in large numbers. Micro­
scopic examination of sections of the cerebellum, cerebrum and brain 
stem revealed only mild changes. One area had perivascular cuffing 
of deep meningeal vessels with mononuclear cells. 
Changes in the circulating leukocyte profiles following dexametha-
sone treatment were rapid increases in the total leukocyte counts (Fig. 
23) of more than 100% in both treated calves. However, the total lympho­
cyte count (Fig. 23) continued to decrease until the day of death. 
Experiment 2 
Cattle exposed by aerosol to low doses of IBRV showed mild clinical 
responses. Rapid respiration and increased inspiratory sounds on 
auscultation were observed in 3 animals from 2 through 6 DPE. Occasional 
voluntary coughing was observed and coughing could be elicited in 
infected animals by physical manipulation of the trachea. The same 
techniques did not cause coughing in the control cattle. Increased 
amounts of nasal discharge, congestion of the nasal mucosa, and necrotic 
plaques on the nasal mucosa were not observed. Seven of eight exposed 
animals had a febrile response of 2 to 5 days duration beginning 
between 3 and 5 DPE (Table 4). 
IBRV was isolated from 7 of 8 exposed animals (Table 4). Virus 
shedding began from 5 to 12 DPE and was isolated sporadically up to 21 
days after exposure. No virus was isolated from 2 control animals. 
Anti-IBRV antibody developed to near maximal levels 28 DPE in all 
exposed animals (Table 4). No anti-IBRV antibody developed in control 
animals. 
Figure 23. Hematologic changes in calves treated with dexamethasone 
and subsequently exposed to IBRV by the aerosol route. 
Data shown is average of 2 calves. 
# Total leukocytes in peripheral blood of dexamethasone 
treated-IBRV infected calves. 
O——O Total leukocytes in peripheral blood of nontreated 
IBRV infected calves. 
 ^Total lymphocytes in peripheral blood of dexamethasone 
treated-IBRV infected calves. 
Total lymphocytes in peripheral blood of nontreated 
IBRV infected calves. 
I Dexamethasone treatment began. 
 ^ All exposed to IBRV. 
• 1 of 2 calves died. 
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Table 4. Clinical, serological and virological response of 6-month-old 
calves following aerosol exposure to IBRV Colo and LA strains. 
Calf IBRV Virus 
Number Strain^  
y 
Fever Isolation Antibody 
6973 LA 5-7 7-16,19,21 16 
6975 LA 0 8,10,12 16 
7018 LA 3,5,6,7,10 5,8,9 16 
7025 LA 5,6,8 0 2 
6966 Colo 3-10 9-16 16 
6967 Colo 5-12 8-16 64 
7016 Colo 5-9 12 32 
7017 Colo 4-8 6,8,10,13 32 
7019 None 0 0 >2 
7020 None 0 0 >2 
L^A = Los Angeles strain; Colo = Colorado strain (See text for 
strain history). 
D^ay or days post exposure when rectal temperature exceeded 39.4 C. 
D^ays post exposure when IBRV was isolated from nasal secretions. 
R^eciprocal of serum dilution neutralizing 50% of plaques in SVN 
test. Samples taken 28 days after exposure. 
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Following challenge-IBRV-exposure, none of the previously exposed 
animals had clinical evidence of respiratory infection or shed virus in 
their nasal secretions during the two-week observation period. Challenge 
control animals showed evidence of disease similar to, but more severe 
than, that observed in the initial exposure (Table 5). All animals had 
an increase in antibody response by 14 days post challenge. 
Cattle that had been exposed by aerosols of IBRV and challenged 
6 months later by aerosol developed typical DTH skin test responses when 
injected intradermally with 0.05 ml of inactivated IBRV antigen pre­
pared from IBRV-infected BT cells. Positive responses were recorded 
at 24 and 48 hours following injection of the antigen intradermally 
in the neck (Fig 24A) and caudal fold (Fig. 25A) sites. There seemed 
to be no direct correlation between the size of the DTH reaction and 
the anti-IBRV antibody titer in the serum of sensitized animals (Table 6). 
Dexamethasone treatment (30 mg intravenously for 10 days) caused a 
marked reduction in the DTH skin test response (Figs. 24B and 25B) in 
all animals and induced necrotic nasal mucosal plaques and virus 
secretion in nasal mucus of 5 of 8 animals treated. Humoral antibody 
titers increased following recrudescence of IBRV lesions (Table 6). 
Administration of the skin test by intradermal injection of 0.05 ml of 
inactivated IBRV antigen at 2 different sites (heck and caudal fold) 
caused a marked hyperthermia in all animals tested (Fig. 26). The 24-
hour temperature increase in different individuals varied from 1.8 to 
4.0 F above the average temperature computed from 9 days of temperature 
recordings prior to the test. 
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Table 5. Clinical, serological and virological response of calves 
previously exposed to IBRV (LA and Colo strains) and controls 
when challenge-exposed 6 weeks later to IBRV Colo by the 
aerosol route. 
Calf 
Number Fever^  
Virus  ^
Isolation 
Antibody^  
Pre-challenge Post-challenge 
6973 0^  0 32 64 
6975 0 0 32 64 
7018 0 0 16 32 
7025 0 0 4 32 
6966 0 0 32 64 
6967 0 0 32 32 
7016 9,10,13,14 0 32 ND® 
7017 0 0 16 32 
7019 2-6,9 6,7,10,11 >2 16 
7020 2-6,9,10,14 2-11 >2 16 
R^eciprocal of serum dilution neutralizing 50% or more of the 
plaques in SNV test. Pre-challenge serum sample taken 70 days after 
initial exposure and post-serum sample taken 14 days post-challenge. 
D^ay post-exposure when rectal temperature exceeded 39.4 C. 
D^ays post-exposure when IBRV was isolated from nasal secretions. 
N^o isolations. 
N^ot determined 
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Table 6. Serological and delayed-type hypersensitivity (DTH) 
responses to intradermal injection of inactivated IBRV 
antigen before and after dexamethasone treatment that 
caused recrudescence in chronically infected cattle-
Animal DTH Response^  Antibody Response^  Virus 
Number Pre-tr. Post-tr. Pre-tr. Post-tr. Isolations 
7025 ++++ + 32 128 8 
6966 ++++ + 64 256 6-12 
6973 +++ + 64 >256 6-15,18 
6975 +++ + 64 256 0 
7016 ++ + 32 256 0 
7019 ++ + 16 128 10,11,13 
7020 ND 32 64 4-8,9—13 
2017 ND 64 64 0 
E^ach + represents approximately 1 cm. diameter by 0.5 cm. 
thickness of swollen skin at injection site. 
R^eciprocal of serum dilution neutralizing 50% or more of 
the plaques in SVN test. Pre-treatment (Pre-tr.) taken 10 days 
before and post-treatment (Post-tr.) taken 6 days after dexametha­
sone treatment. 
D^ays after first day of dexamethasone treatment when IBRV 
was isolated from nasal secretion. 0 = no isolations. 
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Figure 25. Delayed-type hypersensitive (DTH) response following 
intradermal injection of inactivated IBRV antigen into 
the skin of the caudal fold. 
A. DTH response of chronically IBRV-infected steer before 
dexamethasone treatment. Arrow indicates area of IBRV 
antigen injection. Opposite side injected with cell 
control antigen. 
B. Reduced DTH response in same steer after 10 days of 
treatment with dexamethasone. Arrow Indicates area 
of IBRV antigen injection. Opposite side injected 
with cell control antigen. 
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Figure 26. Rectal temperature of cattle following intradermal skin 
testing with inactivated IBRV antigen. 
# I # Daily average of 6 cattle tested. 
0»"0 Daily average of 2 nontested controls. 
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Results of determinations for biochemical changes in plasma 
following dexamethasone treatment are recorded in Table 7. Only means 
of separate determinations on all 8 cattle at each specific time are 
recorded. Obvious increases in SCOT (serum glutamic oxalacetic trans­
aminase) , alkaline phosphatase, uric acid, and glucose began at 4-8 
hours post treatment and remained elevated throughout the treatment 
period. Decreases in cholesterol and inorganic phosphorous were 
recorded during the same period of time. LDH (lactic dehydrogenase), 
total bilirubin, albumin, total protein, BUN (blood urea nitrogen) 
and calcium levels were not significantly changed. 
Adrenal output of 17-dehydroxycortisone (DHC) was depressed in 
all 8 dexamethasone treated cattle (Table 8). Plasma samples drawn 
1 hr after the initial intravenous injection of dexamethasone had a 
marked decrease of 17-DHC and by 8 hr post injection (P.I.) the natural 
hormone was depressed below detectable levels in all but one animal 
(Table 8). Three of 8 animals began a rebound effect by 12 hr P.I. 
This effect was more obvious in all eight animals 24 hr P.I.; however, 
30 hr after the initial injection (6 hr after 2nd injection) all animals 
had little or no detectable 17-DHC in their plasma. Throughout the rest 
of the treatment period samples drawn 24 hr after the previous dexa­
methasone injection remained at less than 50% of the average base line, 
pretreatment levels (Fig. 27). 
The blastogenic response of isolated lymphocyte microcultures 
established from IBRV infected cattle prior to, during, and following 
dexamethasone treatment was measured by the evaluation of tritiated 
Table 7. Biochemical changes in bovine plasma during dexamethasone-
induced IBRV recrudescence. Data is mean results of separate 
determinations on plasma drawn from 8 different cattle at 
times indicated 
Plasma Time - Days or Hours Pre-
Constituent -50 -30 0 hr. 1 hr. 2 hr. 4 hr. 8 hr. 
SCOT 39.25 43.63 52.75 52.0 51.38 50.75 64.38 
LDH 540.63 558.25 615.63 564.88 567.63 597.63 575.86 
Alk. Phos. 56.25 52.75 54.0 55.13 52.38 53.25 68.25 
T. Bill. 0.20 0.19 0.125 0.113 0.10 0.10 .125 
Alb. 3.29 3.25 3.40 3.43 3.71 4.65 3.48 
T.P. 6.3 6.45 6.50 6.51 6.34 6.3 6.79 
Choi. 172.50 187.13 171.50 161.25 153.13 159.63 204.88 
Uric Acid 0.58 0.48 0.64 0.54 0.65 0.61 0.99 
BUN 11.5 12.0 12.0 13.50 13.50 12.63 13.13 
Glu. 69.63 67.25 58.38 68.25 71.0 78.63 79.0 
Inor. Phos. 6.2 6.8 7.19 6.58 5.99 5.49 5.56 
Ca"*^  8.5 8.49 8.54 8.39 8.2 8.31 8.49 
T^otal increase due to one unusually high value. 
100 
or Post Dexamethasone Treatment (30 mg I.V.) 
12 hr. 24 hr. 48 hr. 72 hr. 96 hr, 2 Day 9 Day 28 Day 
60.63 53.13 51.13 51.0 42.14 100.38 225.25 56.86 
513.75 544.13 483.38 534.38 372.14 392.86 615.75^  612.6 
60.50 57.38 59.25 67.75 79.14 100.50 99.13 46.5 
0.113 0.075 0.075 0.075 0.10 0.125 .325* .125 
3.99 4.10 4.13 4.19 3.99 3.91 3.88 3.86 
6.66 6.50 6.50 6.63 6.47 6.43 6.36 6.46 
167.63 142.63 138.25 137.0 122.14 103.0 111.63 135.5 
.75 .64 .825 1.04 .86 1.03 1.01 .61 
12.0 15.25 13.88 13.75 14.43 14.5 13.86 14.38 
105.63 121.25 101.38 100.5 93.57 89.13 92.38 62.25 
4.90 4.36 3.98 4.51 4.86 4.56 4.65 6.99 
8.54 8.31 8.54 8.51 8.63 8.41 8.25 8.51 
Table 8. Changes in bovine plasma levels of 17-hydroxycortisone^  during dexamethasone-induced 
IBRV recrudescence. 
Animal Time - Days or Hours Pre- or Post-Dexamethasone Treatment 
Number -6Da -5Da -3Da 0 Hr^  1 Hr 8 Hr 12hr 25hr 30hr 48hr 72hr 96hr 5 Da 6 Da 7 Da 
6966 1. 67 1. 28 1.16 2. 32 0.99 0.00 0. 46 0.60 0.00 0.10 0.25 0.45 0.70 0.35 0.55 
6973 1. 72 0. 70 0.78 0. 65 0.57 0.00 0. 34 0.30 0.00 0.20 0.50 0.70 0.55 0.40 0.30 
6975 2. 29 1. 17 0.91 0. 96 0.65 0.00 0. 52 0.20 0.00 0.00 0.60 0.50 0.45 0.45 0.50 
7016 0. 99 0. 65 0.65 1. 48 0,78 0.00 0. 00 0.03 0.00 0.00 0.70 0.55 0.50 0.00 0.55 
7017 1. 67 0. 63 2.08 4. 43 1.43 0.00 0. 00 0.46 0.20 0.20 0.75 0.00 0.50 0.60 0.60 
7019 1. 61 0. 56 1.54 1. 17 0.42 0.00 0. 00 0.34 0.00 0.00 0.60 0.80 0.50 0.55 0.50 
7020 0. 55 0. 63 1.04 0. 73 0.39 0.13 0. 05 0.30 0.20 0.69 0.55 0.50 0.60 0.35 0.35 
7025 1. 56 0. 70 0.47 1. 69 0.52 0.00 0. 00 0.20 0.20 0.25 0.45 0.50 0.70 0.50 0.20 
D^ata recorded as yg % (micrograms/100 ml plasma). Analyses provided courtesy Dr. S. C, 
Whipp, National Animal Disease Center, Ames, Iowa. For method used see Whipp and Lyon (1970). 
Dexamethasone treatment begun. 
Figure 27. Plasma 17-dehydroxycorticosterone levels before and 
during dexamethasone-induced IBRV recrudescence. 
Data entered is mean of results of separate determinations 
on plasma taken from 8 different cattle at times indicated. 
Indicates time sequence of dexamethasone treatment. 
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3 thymidine ( HdT) uptake. The stimulation indices (Si's) of these 
cultures to PHA-M and inactivated IBRV antigen are recorded in Table 9. 
The PHA-M stimulation index (SI) was depressed from a pretreatment average 
of 30.0 to 6.9 within 24 hours of the beginning of dexamethasone 
treatment, remained at similar low levels for 72 hours and gradually 
returned to near pretreatment levels even during treatment (Table 9). 
IBRV Sis of cultures from chronically IBRV-infected cattle showed a 
distinct increase within 48 hours of the initial treatment (Table 9) 
and returned to pretreatment levels 7 days after dexamethasone treat­
ment ceased. IBRV Sis of noninfected control animals were negative 
and showed no appreciable change during the treatment period. A 
composite histogram illustrating the mean PHA-SIs of all dexamethasone 
treated cattle and 2 noninfected controls is shown in Fig. 28. It 
should be noted that the increase in IBRV-SIs occurs rapidly after 
the PHA-SI depression. A more graphic illustration of this effect 
can be demonstrated by plotting the individual Sis of animal #7016 
(Fig. 29). 
Dexamethasone treatment decreased the percentage of T lymphocytes 
in the circulating lymphocytes of all cattle treated (Table 10). 
Pretreatment base line T lymphocyte percentages ranged from 73.2 to 
94.6 and averaged 83.5%. The lowest group average of 67.8% occurred 
on post treatment day 6 and in one individual (//7138) only 52% of the 
lymphocyte pool were T lymphocytes. T lymphocyte depression became 
obvious 4 days post treatment (Fig. 30), reached a maximum at 6 days 
post treatment and had not returned to normal levels 12 days after 
treatment was stopped. 
Table 9. Blastogenic response of microcultures of isolated lymphocytes 
from chronically IBRV-infected and control cattle to phyto-
hemagglutinin-M (PHA-M) and inactivated IBRV-A antigen (Ag) 
before and after dexamethasone treatment. Each animal was 
given 30 mg. of dexamethasone intravenously for 10 consecur-
tive days beginning March 18, 1974. 
3/4/74 3/11/74 3/18/74 3/20/74 3/22/74 
Animal PHA® IBR PHA IBR PHA IBR PHA IBR PHA IBR 
Number SI SI SI SI SI SI SI SI SI SI 
6966 96.3 15.3 33.5 8.5 27.7 10.4 2.1 5.5 5.5 32.5 
6973 51.3 5.0 26.2 5.4 32.6 4.5 8.5 4.5 26.1 5.4 
6975 32.2 4.7 22.9 3.9 17.4 3.9 9.9 4.2 29.0 5.7 
7016 29.9 5.7 20.9 5.3 21.2 5.7 4.4 2.8 7.8 5.0 
7019 28.1 .8 11.7 1.6 12.7 1.2 1.6 .9 7.0 1.7 
7020 21.0 1.7 17.1 1.8 21.4 1.7 3.2 1.2 14.1 1.3 
7025 32.2 4.1 5.3 .9 24.4 3.3 10.2 3.0 31.6 8.8 
7126^  50.5 .4 19.4 .5 36.7 .7 12.0 .6 17.0 .6 
7138^  70.0 .4 32.9 1.1 12.3 1.0 10.0 1.0 24.4 .8 
ZIBR+^  5.33 4.0 4.8 3.2 8.6 
2IBR-® .4 .8 .9 .8 .7 
ZPHA-SI 45.7 21.1 22.9 6.9 18.1 
P^HA-SI = PHA-M stimulation index. 
I^BR-SI = IBRV stimulation index 
C^ontrols, noninfected. 
'Sfean IBRV-SI infected cattle 
M^ean IBRV-SI controls 
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3/24/74 3/26/74 4/4/74 4/9/74 4/16/74 
PHA IBR PHA IBR PHA IBR PHA IBR PHA IBR 
SI SI SI SI SI SI SI SI SI SI 
13.3 31.0 
27.3 4.1 
16.3 3.7 
4.6 9.7 
2.0 1.1 
11.3 1.9 
14.4 2.2 
19.9 .8 
16.6 .9 
7.7 
.9 
14.0 
18.4 23.0 
44.1 3.8 
13.3 2.3 
4.2 12.4 
47.5 .9 
11.3 1.3 
28.7 9.8 
28.5 .6 
18.1 .9 
7.6 
. 8  
28.3 
27.8 12.0 
35.7 7.4 
32.3 6.6 
29.2 15.0 
14.3 2.4 
17.2 3.4 
34.0 8.8 
27.9 .8 
37.9 1.9 
7.9 
1.4 
28.5 
22.5 8.1 
40.9 6.9 
20.4 6.8 
20.4 5.1 
16.0 2.1 
19.5 3.2 
24.6 6.1 
36.2 .6 
13.8 1.3 
5.5 
1.0 
23.8 
16.1 2.4 
58.9 2.8 
74.5 3.9 
NT NT 
NT NT 
51.0 1.7 
33.6 8.1 
NT NT 
21.1 1.4 
3.8 
1.4 
36.9 
Figure 28. Blastogenic response of microcultures of isolated 
lymphocytes from chronically IBRV infected and control 
cattle to phytohemagglutinin-M (PHA-M) and inactivated 
IBRV antigen following intravenous dexamethasone 
treatment (30 mg I.V./animal/day). 
# # PHA-M stimulation index. 
O—O IBRV stimulation index, chronically infected cattle. 
IBRV stimulation index, noninfected controls. 
Period of dexamethasone treatment 
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Figure 29. Blastogenic response of microcultures of isolated 
lymphocytes from one animal (#7016) to PHA-M and 
IBRV antigen following dexamethasone treatment. 
The period of treatment was 0 through 10 days. 
# PHA-M stimulation index. 
O" O IBRV stimulation index. 
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Table 10, Effect of dexamethasone treatment on percentage of Trlymphocytes In Ficoll-Hypaque 
isolated portions of circulating lymphocyte pools of cattle. Each animal was given 
30 mg. of dexamethasone intravenously for 10 consecutive days beginning 3/18/74 
Animal , Date T lymphocyte percentage was determined 
Number 2/12/74 2/25/74 3/4/74 3/11/74 3/18/74^ 3/20/74 3/22/74 3/24/74 3/26/74^ 4/4/74 4/9/74 
6966 79.0 85.1 83.2 84.5 82.2 75.0 83.0 75.0 69.0 86.0 79.0 
6973 82.5 86.0 81.5 84.9 81.3 82.0 74.0 61.0 63.0 78.0 76.0 
6975 89.6 92.2 81.1 81.9 90.7 80.0 80.0 58.0 77.0 84.0 78.0 
7016 ND^ 88.3 75.6 86.7 88.9 79.0 67.0 72.0 82.0 66.0 82.0 
7019 85.4 87.4 80.0 92.6 85.0 76.0 80.0 76.0 83.0 74.0 76.0 
7020 76.2 85.3 80.9 90.0 87.5 80.0 81.0 76.0 80.0 70.0 83.0 
7025 84.4 88.6 81.5 86.1 87.8 79.0 76.0 65.0 71.0 76.0 78.0 
7126 86.2 94.6 76.7 77.8 84.7 84.0 77.0 74.0 68.0 71.0 72.0 
7138 83.2 ND 79.5 79.6 87.4 81.0 71.0 52.0 66.0 65.0 72.0 
Mean 82.1 88.4 80.0 84.9 86.2 79.6 76.6 67.8 73.2 77.4 77.3 
^Dexamethasone treatment began 3/18/74. 
^Dexamethasone treatment stopped 3/27/74. 
*^ND = Not Determined. 
Figure 30. Effect of dexamethasone treatment of cattle on percentage 
of T lymphocytes in their circulating lymphocyte pools. 
Data plotted are mean of separate determinations on 9 cattle. 
Data from 1 (#6973) of 9 are plotted separately. 
Mean of separate determinations of 9 cattle. 
0*0 Determinations of 1 individual (#6973). 
Period of dexamethasone treatment. 
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In experiment 3 it was interesting to compare the results of 
IBRV isolation attempts from nasal secretions. Cattle that secreted 
virus for several days in nasal mucus following initial exposure also 
secreted virus for several days following dexamethasone treatment 
(Table 11). Conversely, cattle from which little or no virus was 
isolated after initial exposure also secreted little or no virus 
from the nasal passages following dexamethasone treatment even though 
they had high levels of anti-IBRV antibodies in their serum. 
Histopathological examination of skin taken by surgical biopsy 12 hr 
post intradermal injection of IBRV antigen revealed early necrotic changes 
in the stratified squamous epithelium of the dermis and edema of the sub­
cutaneous tissues. Accumulation of inflammatory cells in the interstitial 
areas were composed primarily of neutrophils and lymphocytes (Fig. 31A). 
Small blood vessels had perivascular accumulations of lymphocytes (Fig. 
31B). The histopathologic changes in the 24 hr biopsy section were sim­
ilar to those of the 12 hr specimen. Necrosis of the stratified squamous 
epithelium was prominent over the injection site in the 24 hr biopsy 
sample (Fig. 31C). Perivascular accumulations of small lymphocytes 
around the small vessels were more pronounced and more widely dissemi­
nated (Fig. 31D). Neutrophil accumulations were not as prominent in the 
48 hr biopsy (Fig. 32A) sections as in the 12 and 24 hr sections. The 
lymphocyte and macrophage accumulation was the predominant inflammatory 
cell present. The 72 hr biopsy section (Fig. 32C) had few neutrophils 
but the perivascular accumulation of lymphocytes and macrophages was not 
markedly changed from that seen in earlier biopsies. 
Table 11. Comparisons of IBRV shedding in nasal secretions during initial (IE), first 
dexamethasone induced recrudescence (Rl) and second recrudescence (R2). 
Animal Dyas Pre- or Post-Treatment of Exposure^ 
Number Event -1 -2 -3 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
6966 IE - - - - + + + + + 
R l  —  —  —  —  —  —  —  —  —  4 -  +  4 - 4 - 4 -  +  +  —  —  —  
R 2  -  -  -  -  - -  +  +  +  +  +  +  N D +  N D N D N D N D N D  
6973 IE - - - - + + + + + + 
Rl - - - - + + + + 
R 2  -  -  -  - - - -  +  +  +  +  +  N D  +  N D  N D  N D  N D  N D  
6975 IE — — — — — — — — — — — — "t" — "t" ^ ta — 
Rl - - - - -- -- -- -- --
R2 - - - - -- -- -- -- ND - ND ND ND ND ND 
Rl - - - - -- -- -- -- --
R2 - - - - -- -- -- -- ND - ND ND ND ND ND 
7019 IE — — — — — — — — — + + — — + + - — — — 
Rl — — — — — — — — — — — — — + + + — — — 
R 2  -  -  -  -  - -  +  +  +  +  +  +  N D  +  N D N D N D N D N D  
7020 IE — — — — — + + + + + + + + — — — — — — 
Rl — — — — — — — + + + + + — + + + + + — 
R 2  -  -  -  -  - - - -  +  +  +  +  +  N D  -  N D  N D  N D  N D  N D  
7025 IE - - - - -- -- -- -- --
Rl - - - - -
R2 - - - - -- -- -- -- ND - ND ND ND ND ND 
^-Virus isolations attempted but none isolated, +virus Isolated from nasal secretions, 
ND Not determined. 
Figure 31. Tissue sections made from surgical biopsies of skin test 
reaction to intradermal injection of inactivated IBRV 
antigen. 
A. 12 hr post injection (PI) biopsy. 
B. Perivascular accumulation of mononuclear cells 12 hr 
PI biopsy. 
C. 24 hr PI biopsy. Note necrosis of stratified squamous 
epithelium (top). 
D. Perivascular accumulation of mononuclear cells 24 hr 
PI. Hematoxylin and eosin stain. 
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Figure 32. Tissue sections made from surgical biopsies of skin 
test reaction to intradermal injection of inactivated 
IBRV antigen. 
A. 
00 
hr post injection 
B. 48 hr PI. 
C. 72 hr PI. 
D. 72 hr PI. 
Hematoxylin and eosin stain. 
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Dexamethasone treatment suppressed the development of necrosis, 
swelling and edema and virtually eliminated the infiltration of the 
area with neutrophils (Fig. 33). However, the mononuclear cellular 
infiltrate did not appear to be markedly reduced (Figs. 33 and 34). 
Experiment ^  
All calves exposed to IBRV, Colo, Jensal, and K-22 strains by the 
intranasal route developed acute respiratory disease characterized by 
hyperthermia (Fig. 35), rapid respiration, anorexia and early development 
of focal necrotic lesions of the respiratory epithelium in the anterior 
nares. There were no obvious differences in the extent or degree of 
clinical illness except that IBRV Colo strain-infected calves had an 
elevated rectal temperature for a longer period of time than those 
exposed to other strains (Fig. 35). All calves secreted virus in their 
nasal mucus from 1 to 8-14 days after exposure. Only one calf (#7472) 
secreted virus for more than 10 days post exposure (Table 12). 
The blastogenic response to inactivated IBRV antigen as measured 
by the uptake of tritiated thymidine was not detectable by the method 
used through 3 weeks post exposure. No differences in response to 
homologous or heterologous antigens were detected. Only lymphocyte 
cultures from calves having had repeated skin tests with inactivated 
IBRV antigen gave a stimulation index more than 2.0 (Fig. 36). 
Dexamethasone treatment (30 mg I.V. daily) 6 months after initial 
exposure caused IBRV reactivation in all 5 calves. One calf died of 
bloat 5 months post exposure. No major differences in clinical illness 
nor secretion of virus in nasal mucus could be detected between strains 
(Table 12). 
Figure 33. Tissue sections made from surgical biopsies of skin 
test reaction to intradermal injection of inactivated 
IBRV antigen after 10 days of dexamethasone treatment. 
A and B. 12 hr post injection (PI) 
C and D. 24 hr PI. 
Hematoxylin and eosin stain. 
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Figure 34. Tissue sections made from surgical biopsies of skin 
test reaction to intradermal injaction of inactivated 
IBRV antigen after 10 days of dexamethasone treatment. 
A. 
00 
hr PI. 
B. 48 hr PI. 
C. 72 hr PI 
D. 72 hr PI 
Hematoxylin and eosin stain. 
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Figure 35. Rectal temperature of calves following aerosol exposure 
to IBRV Colo, Jensal and K-22 strains by the intranasal 
route. 
Data plotted are means of daily temperatures of 2 animals 
exposed to each IBRV strain. 
# Two calves exposed to Jensal strain IBRV. 
O—"O Two calves exposed to K-22 strain IBRV. 
Two calves exposed to Colo strain IBRV. 
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Figure 36. Inmunostimulation of microcultures of isolated lymphocytes 
due to exposure to inactivated IBRV antigen following 
IBRV exposure and skin testing with inactivated IBRV 
antigen. 
Data are results from one animal (#7466). 
1 IBRV skin test administered. 
IBRV recrudescence due to dexamethasone treatment. 
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Table 12, IBRV isolations from nasal secretions following intranasal inoculation of 
Colo, Jensal, and K'r22 strains of IBRV and reactivation of infection 6 months 
later with dexamethasone treatment (30 mg I,V./day for 10 days). 
Animal Days Post Exposure of Post Dexamethasone Treatment 
Number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
7465^ IE + + ND + ND + ND + ND + ND _ ND _ 
R1 - - - - + + + + + + + - ND -
7472^ IE + + ND + ND + ND + ND + ND + ND + 
R1 + + + + + + + ND - ND -
7471^ IE 
Rl^ 
+ + ND + ND + ND + ND — ND + ND -
7469^ IE + + ND + ND + ND + ND — ND — ND — 
R1 - - - — - + + + + - + - ND -
7454"^ IE + + ND + ND + ND + ND — ND - ND — 
R1 - - - + + + + + + + + - ND -
7466'^ IE + + ND + ND + ND + ND + ND _ ND — 
R1 — — — + + + + + + + + ND 
^Initially exposed to IBRV-Colo strain. 
^Initially exposed to IBRV IPV-K22 strain. 
^Animal died from bloat. 
^Initially exposed to IBRV-Jensal strain. 
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Experiment _5 
All calves exposed to IBRV by aerosol became severely ill with 
acute upper respiratory disease except the two controls. All 6 of 
the nonimmune calves experienced extreme difficulty in breathing 
from 4-10 days post exposure to such an extent that penicillin-
streptomycin was administered intramuscularly to 2 animals for 3 
consecutive days. Anorexia, hyperthermia and depression were more 
prominent in these calves than is usual in experimentally IBRV-exposed 
calves. However, all calves were making rapid recovery by 12-14 days 
post exposure. 
IBRV was isolated from 1 to 12 days post exposure from all non­
immune calves, but only on 1 day from immune controls. 
The blastogenic response of IBRV-Ag stimulated microcultures 
of isolated lymphocytes taken from the nonimmune calves during the 
period of illness failed to reach levels considered to be positive. 
Cultures prepared every other day for 2 weeks, weekly thereafter 
through 8 weeks and at variable intervals thereafter for 178 days 
failed to produce stimulation indices above 2.0 (Fig. 37). Positive 
controls remained high throughout the same period. The blasto­
genic response to PHA-M was at usual high levels throughout the 
entire test period. 
Whole blood cultures from nonimmune calves began showing positive 
IBRV-Ag blastogenic responses early and reached maximum levels by 6 
days post exposure (Fig. 38). Although the whole blood culture specific 
mitogen-induced response fell slightly at 12 to 14 days post exposure it 
remained relatively high throughout the 6 month test period. Toward the 
Figure 37. Blastogenic response of isolated lymphocyte microcultures 
to IBRV inactivated antigen (IBRV-Ag) following aerosol 
exposure of cattle to IBRV. 
O—O Positive controls, average of 2 cattle. 
IBRV initial exposure, average of 6 cattle. 
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Figure 38. Blastogenic response of whole blood cultures to IBRV 
inactivated antigen (IBRV-Ag) following aerosol exposure 
of cattle to IBRV, 
O—O Positive controls, average of 2 cattle. 
# IBRV initial exposure, average of 6 cattle. 
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end of the test period (Fig. 38) the IBKV stimulation indices appeared 
to wane slightly. No skin testing or chemical recrudescence were con­
ducted in this period of time. 
Approximately 1 year following the initial exposure base line 
evaluations of specific antigen and phytomitogenic responses were 
evaluated in whole blood cultures and isolated lymphocyte microcultures 
prepared from all eight original animals in this experiment and one 
other nonimmune calf that was to be used as a negative control. 
Dexamet has one treatment 1 year following initial exposure to 
IBRV caused recrudescence of nasal mucosal plaques and secretion of 
IBRV from the nasal mucus of 3 of 3 calves from 4 days post treatment 
(DPT) until calves were killed on DPT 9 (Table 13). Cyclophosphamide 
treated cattle were anorectic and showed evidence of dehydration from 
day 2 or 3 post treatment until the animals were killed on DPT 9. 
There was no clinical evidence of IBRV infection. Focal erosions of 
mucosa of the buccal cavity were obvious from day 6-9 post cyclophos­
phamide treatment. IBRV was isolated from the nasal secretion of 1 steer 
(#7736) on DPT 8 (Table 13). Control animals had no evidence of clinical 
illness nor secreted virus in the nasal mucus during this period. 
Total leukocyte numbers in the peripheral blood were elevated 
markedly in all dexamethasone treated calves beginning DPT 1 (Fig, 39). 
Conversely leukocyte numbers in the peripheral blood of cyclophosphamide 
treated animals was depressed beginning on the 3rd day post treatment 
(Fig. 39). Leukocyte numbers were within normal limits in nontreated 
animals throughout the experiment (Fig. 39). 
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Table 13. IBRV isolations from nasal secretions of chronically 
infected cattle following immunosuppression with 
dexamethasone and cyclophosphamide. 
Animal Days Pre- or Post-Treatment 
Number Treatment 
1—1 m
 1 2 3 4 5 6 7 8 9 
7736 Cy^  -
7737 Cy 
7738 Cy 
7741 Dex^  — — — — + + + + + + 
7746 Dex — — — — + + + + + + 
7748 Dex — — — — + + + + + + 
7465^  None 
7466^  None 
7436® None 
C^yclophosphamide injected intravenously (4 mg/kg 1st 4 days, 
then 2 mg/kg for 5 days) 
Viral isolate positively identified as IBRV by serological 
methods. 
D^examethasone injected intravenously (30 mg/animal/day, 0-9). 
I^BRV immune nontreated controls. 
I^BRV nonimmune, nontreated controls. 
Figure 39. Effects of dexamethasone and cyclophosphamide treatment 
on peripheral leukocytes of cattle with chronic IBRV 
infections. 
 ^Average of 3 dexamethasone treated cattle. 
O—O Average of 3 cyclophosphamide treated cattle. 
# Average of 2 nontreated control cattle. 
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The dexamethasone-induced leukocytosis was due to a distinct 
neutrophilia in treated cattle (Fig. 40). Neutrophil numbers rose 
sharply at exactly the same intervals as total leukocytes. Lympho­
cytopenia developed during the concurrent leukocytosis and neutro­
philia (Fig. 40) in dexamethasone treated cattle. 
Cyclophosphamide-induced leukopenia in treated cattle was due 
to a distinct drug-induced neutropenia (Fig. 41). Neutrophil numbers 
decreased gradually during the treatment period. 
Results of the determination of B cell - T cell ratios of isolated 
lymphocyte populations indicate that dexamethasone caused a pronounced 
depression of the percent of T cells in this lymphocyte population 
(Fig. 42). Cyclophosphamide caused an increase in the percentage of 
T cells because of its selective toxic effect on B cells (Fig. 42). 
B cell - T cell ratios remained relatively constant in nontreated controls. 
The blastogenic response of isolated lymphocyte microcultures 
to phytomitogens (PHA-M) during dexamethasone and cyclophosphamide 
treatment is presented in Fig. 43. The PHA-M blastogenic response 
reflected in the stimulation index rose sharply from pre-treatment base 
line levels in cyclophosphamide treated cattle. The PHA-M induced 
blastogenic response in isolated lymphocyte microcultures showed a 
depression due to dexamethasone treatment whereas those of control 
animals remained relatively constant. 
IBRV-Ag induced blastogenic responses of isolated lymphocyte micro-
cultures in cyclophosphamide-treated cattle rose slightly following 
treatment whereas dexamethasone treatment apparently caused a slight 
Figure 40. Effects of dexamethasone treatment on neutrophil and 
lymphocyte segments of the peripheral leukocyte population 
of cattle with chronic IBRV infections. 
Total leukocytes, average of 3 cattle. 
Total neutrophils, average of 3 cattle. 
Total lymphocytes, average of 3 cattle. 
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Figure 41. Effects of cyclophosphamide treatment on the neutrophil 
and lymphocyte segments of the peripheral leukocyte 
population of cattle with chronic IBRV infections. 
# # Total leukocytes, average of 3 cattle. 
 ^Total neutrophils, average of 3 cattle. 
O—O Total lymphocytes, average of 3 cattle. 
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Figure 42. Effects of dexamethasone and cyclophosphamide treatment 
on percent of T cells in isolated lymphocytes of cattle. 
# I # Percent T cells in lymphocytes of dexamethasone 
treated cattle (average of 3). 
O—O Percent of T cells in lymphocytes of cyclophosphamide 
treated cattle (average of 3). 
Percent of T cells in lymphocytes of nontreated cattle 
(average of 2). 
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Figure 43. Blastogenic response of isolated lymphocyte microcultures 
to PHA-M following dexamethasone and cyclophosphamide 
immunosuppression in chronically IBRV infected cattle. 
# I # Average of 3 cyclophosphamide treated cattle. 
O Average of 3 dexamethasone treated cattle. 
#—# Average of 3 nontreated control cattle. 
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decrease in treated cattle. The negative and positive responding 
controls remained at relatively constant levels throughout the entire 
experiment (Fig. 44). 
The blastogenic response of whole blood cultures to phytomitogen 
(PHA-M) is presented in Fig. 45. Cultures from cyclophosphamide 
treated cattle responded with a dramatic increase in stimulation 
indices when exposed to PHA-M. A slight depression of PHA-M stimu­
lation was evident in cultures from dexamethasone treated cattle and 
control nontreated animals showed little or no change. 
IBRV-Ag induced blastogenic responses in whole blood cultures 
established from cyclophosphamide treated cattle were markedly decreased 
following treatment (Fig. 46). Dexamethasone treated cattle had less 
marked decrease except for post treatment day 5. Cultures from 
positive nontreated controls showed a rise in IBRV-Ag Sis but the 
nonimmune negative control stayed fairly constant. 
Dexamethasone and cyclophosphamide treated, chronically IBRV-
infected cattle killed and necropsied 9 days following the initial 
treatment were examined for gross pathologic lesions. All three 
dexamethasone treated cattle had multifocal necrotic plaques and 
erosions in the mucosal surfaces of the anterior nares, nasal septum, 
and pharyngeal area. Two cattle (#7741 and #7746) had moderate areas 
(3x6 cm) of consolidation in the ventral portion of the anterior 
and cardiac lobes of the lungs. IBRV was isolated from pharyngeal 
lesion tissues of 2 of 3 cattle, but not from lung, trachea, or asso­
ciated lymphatic tissue. An interesting incidental cytopathic agent was 
Figure 44. Blastogenic response of isolated lymphocyte-microcultures to 
IBRV inactivated antigen (IBRV-Ag) following dexamethasone 
and cyclophosphamide immunosuppression in chronically IBRV 
infected cattle. 
# # Average of 3 cyclophosphamide treated cattle. 
0--0 Average of 3 dexamethasone treated cattle. 
 ^Average of 2 positive nontreated control cattle. 
O-O Negative, nonimmune, nontreated control. 
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Figure 45. Blastogenic response of whole blood cultures to PHA-M 
following dexamethasone and cyclophosphamide immuno­
suppression in chronically IBRV infected cattle. 
# Average of 3 cyclophosphamide treated cattle. 
O—O Average of 3 dexamethasone treated cattle. 
Average of 3 nontreated control cattle. 
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Figure 46. Blastogenic response of whole blood cultures to IBRV 
inactivated antigen (IBRV-Ag) following cyclophosphamide 
immunosuppression of chronically IBRV infected cattle. 
 ^Average of 3 cyclophosphamide treated cattle. 
O—~0 Average of 3 dexamethasone treated cattle. 
Average of 2 positive, nontreated control cattle. 
O-O Negative, nonimmune, nontreated control. 
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isolated from the consolidated lung tissue of calf #7741. This agent was 
isolated in EBT cells and identified by serological and electron micro­
scopic methods as belonging to the suggested bovid herpesvirus 5 group 
(Smith 1977). 
Erosive noninflammed lesions of the buccal mucosa especially 
around the gingiva were observed in 2 of 3 cyclophosphamide-treated 
cattle. Urinary and gall bladders seemed to be distended in all 3 
animals. 
Lymphatic tissues from all dexamethasone and cyclophosphamide 
treated cattle were enlarged and edematous. 
Histopathological examination of hematoxylin and eosin stained 
sections of tissues taken at necropsy from cattle treated with 
dexamethasone revealed an acute to subacute necrotic rhinotracheitis 
and pharyngitis characterized by multifocal areas of epithelial 
ulceration and necrosis with fibrinopurulent exudate over the affected 
surfaces. The stratified squamous epithelium at the edge of the ulcers 
were undergoing ballooning degeneration and occasionally contained 
small intranuclear inclusion bodies. The epithelium of the ducts and 
acini of the serous glands were also undergoing degenerative necrosis. 
The submucosal tissues were infiltrated with lymphocytes, plasma cells 
and macrophages and a few scattered neutrophils. Perivascular cuffs 
of lymphocytes and macrophages were common. 
The tonsils and pharyngeal tonsillar tissues had lymphoid depletion 
and reticular cell hyperplasia. There was a moderate lymphoid depletion 
of splenic tissues from dexamethasone-treated cattle (Fig. 47). A small 
Figure 47. Histological section of spleen from dexamethasone treated 
steer. 
Note lymphoid depletion and reticuloendothelial hyperplasia. 
Hematoxylin and eosin stain. 
Figure 48. Histological section of spleen from dexamethasone treated 
steer. 
Notice light staining central artery and small dark 
staining periarteriolar sheath of lymphoid cells. 
Large, less dense stained circular sheath is composed 
of neutrophils. 
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collar of periarteriolar lymphoid sheaths was surrounded by a distinct 
well-defined area of necrotic cells and neutrophils (Fig. 48). The 
splenic cords were fibrosed and large areas of collagen had been de­
posited in this area. Two of the 3 animals had several areas of chronic 
focal nephritis. The inflammatory cells around the kidney tubules were 
predominantly lymphocytes and plasmacytes. 
Bone marrow sections taken from the 4th rib seemed mildly depleted 
y 
of blast cells and megalokarocytes. There seemed to be an overabundance 
of progranulocytes in the bone marrow (Fig. 49). 
Lymph nodes were moderately depleted of lymphoid germinal centers 
(Fig. 50) and the paracortical zones normally considered to be populated 
with T lymphocytes were devoid of lymphoid cells. Blast type lymphoid 
cells were not present in the germinal centers and had been replaced 
with reticular cells (Fig. 51). 
Tissues taken from the area of the buccal ulcers of cyclophos-
phamide-treated cattle had multifocal areas of well-defined epithelial 
necrosis (Fig. 52). All tissue in this area was denuded to the area 
of the basement membrane. Large filamentous organisms and coccoid 
shaped bacteria were present in large colony type masses in the denuded 
area (Fig. 53). However, there was little or no evidence of inflammatory 
cells in the mucosal or submucosal area. One animal (#7736) had 
several small areas of subacute tracheitis in the anterior portion 
of the trachea. 
Spleens from cyclophosphamide treated cattle showed evidence of 
severe lymphoid depletion (Fig. 54) but small collars of lymphoid 
Figure 49. Histologie section of 
dexamethasone treated 
Hematoxylin and eosin 
bone marrow of 4th rib taken from 
steer. 
stain. 
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Figure 50. Histologie section of a suprapharyngeal lymph node 
from a dexamethasone treated steer. 
Note moderate lymphoid depletion. Hematoxylin and 
eosin stain. 
Figure 51. Lymphoid follicle from suprapharyngeal lymph node of 
dexamethasone treated steer. 
Note reticulo-hyperplasia in center of germinal follicle. 
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Figure 52. Epithelial necrosis in the buccal mucus membrane of 
cyclophosphamide treated cattle. 
Hematoxylin and eosin stain. 
Figure 53. Epithelial necrosis in the buccal mucus membrane of 
cyclophosphamide treated steer. 
Note large filamentous organisms. Hematoxylin and 
eosin stain. 
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Figure 54. Histologie section of spleen from cyclophosphamide 
treated steer. 
Note the severe lymphoid depletion. Hematoxylin and 
eosin stain. 
Figure 55. Depleted germinal center in spleen of dexamethasone 
treated steer. 
Note few lymphoid cells in periarteriolar sheath. 
Hematoxylin and eosin stain. 
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cells remained in the periarteriolar lymphoid sheaths (Fig. 55). Areas 
normally considered to be populated with B cells were remarkably absent. 
All lymph nodes taken from the cyclophosphamide-treated group 
showed evidence of severe lymphoid depletion (Fig. 56) and reticulo­
endothelial hyperplasia. Germinal centers were almost nonexistent. 
Many macrophages had also accumulated at the cortico-medullary junction 
of the lymph node (Fig. 57). These cells lay in large closely packed 
sheets of morphologically homogenous cells. 
The thymus, surprisingly, had little or no evidence of thymic 
depletion or other histopathologic change. 
Bone marrow from cyclophosphamide-treated cattle was depleted 
of blast type cells and megalokarocytes (Fig. 58). The bone marrow 
was markedly depleted from progranulocyte-type cells. 
Figure 56. Histologie section of a suprapharyngeal lymph node 
from a cyclophosphamide treated steer. 
Note severe lymphoid depletion. Hematoxylin and 
eosin stain. 
Figure 57. Reticuloendothelial hyperplasia and macrophage 
accumulation in suprapharyngeal lymph node of 
cyclophosphamide treated steer. 
Hematoxylin and eosin stain. 
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Figure 58. Bone marrow section from steer treated with cyclophosphamide. 
Note absence of megalokaryocyte and progranulocytes. 
Hematoxylin and eosin stain. 
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DISCUSSION 
Dexamethasone-induced immunosuppression of calves prior to and 
during acute IBRV infection transforms a nonlethal illness into a 
disseminated infection causing death. The recovery of IBRV from the 
brains of two dexamethasone tre ited calves raises the question of whether 
the idea of specific tissue tropism of certain strains of IBRV for central 
nervous tissue may actually reflect specific genetic or environmental 
immunodeficient states of the neonatal calves so affected. However, the 
biological differences between neurotropic and nonneurotropic strains 
of IBRV appear real (Bagust 1972) even though other reports indicate 
no biochemical or antigen difference can be detected (Black and Slack 
1972). The disseminated human herpesvirus 2 infections that occur in 
neonates born of infected mothers may be analogous. 
Dexamethasone treatment of cattle with chronic IBRV infections 
caused recrudescence of clinical disease, viral shedding in the nasal 
mucus, and elicited necrotic lesions in the upper respiratory mucosal 
surfaces at 3, 6, and 12 months after initial infection. It is inter­
esting to note that cattle having only very mild signs of disease 
during the initial exposure (experiment 3) had obvious necrotic mucosal 
plaques following dexamethasone treatment. However, the length of time 
that virus was recovered from the nasal secretions following initial 
exposure seemed to correlate well with IBRV recovery patterns following 
drug-induced recrudescence (Table 11). This observation indicates that 
the anti-IBRV immune mechanism of calves vary widely in individuals 
and that the competence to eliminate the initial invading virus may be 
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reflected in decreased viral shedding during recrudescence. It seems 
possible that this same mechanism may not be sensitive to dexamethasone 
treatment. It is interesting to speculate that this might be related 
to the individual's ability to produce specific humoral and secretory 
antibody since dexamethasone seems to be less detrimental to B cells 
than to T cells. 
These data indicate that different field strains and modified live 
virus vaccine strains establish chronic infections in exposed cattle 
and can be reactivated by immunosuppressive factors. They are compatible 
with those of Davies and Duncan (1974) and heightens the suspicions of 
others (Kiesel al^ . 1972; Curtis and Angulo 1974) that challenge the 
wisdom of widespread use of modified live virus vaccines in feeder 
cattle. The chronic infection established with modified live virus vaccines 
in young calves may be reactivated by environmental stress-induced 
immunosuppression during shipment. 
Distinct biochemical changes in blood plasma occurred soon after 
the administration of dexamethasone. The regulatory feed-back mechanism 
of 17-dehydroxycorticosterone production by the adrenal cortex is 
apparently activated by dexamethasone and this activation is reflected 
in the rapid decrease in the natural hormone following dexamethasone 
treatment. Stress related fluctuations of natural hormones may play 
an immunosuppressive role during the shipment and post shipment period 
causing IBRV recrudescence in chronically infected cattle. The changes 
recorded for other plasma constituents are apparently related to the 
gluconeogenic effect of the synthetic corticosteroid. 
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The metabolic changes induced by dexamethasone treatment of 
chronically IBRV-infected cattle are probably directly related to 
the immunosuppressive changes responsible for the reactivation of 
IBRV-induced necrotic mucosal plaques and IBRV secretion in nasal mucus. 
The rapid increase in neutrophils in the peripheral circulation 
after dexamethasone treatment and the continued neutrophilia during 
periods of viral shedding seems to indicate that total numbers of 
neutrophils play no significant role in maintaining the chronic or 
latent state of IBRV infection. However, the increase in total numbers 
of cells, probably brought about by premature release of neutrophils 
from the bone marrow, does not necessarily imply that the functional 
capabilities have not been impaired. These data do not support the 
suggestion by Grewal ^  al. (1977) that neutrophils play a predominant 
role in maintaining IBRV latency. 
Dexamethasone-induced lymphocytopenia precedes recrudescence of 
clinical IBRV in cattle and coincides with the severity of illness in 
drug-modified acute disseminated infections in young calves. Further­
more, the more specific detrimental effect of dexamethasone upon the 
T lymphocyte and a relative sparing of the B lymphocyte population 
indicates that the T lymphocyte plays a major role in maintaining the 
latent IBRV infection in cattle. Further evidence to support this 
contention is provided by the profound B lymphocyte related immuno­
suppressive effect induced by cyclophosphamide treatment without IBRV 
recrudescence. The marked effect upon the B cell population and relative 
sparing effect of the T cell population supports this hypothesis. 
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T lymphocytes are known to be the principal inmunocytes involved 
in delayed hypersensitivity. Results of these experiments showed that 
dexamethasone treatment of IBRV antigen-sensitized cattle caused a 
marked reduction in the DTH response during the reactivation of chronic 
IBRV infections. However, since the number of cells involved in the 
inflammatory response were not obviously diminished it can be assumed 
that the normal cell functions of lymphokine and interferon production 
had been impaired. This hypothesis is supported by reports of others 
(Rhinehart £t al. 1974; Claman 1975; Wahl et al. 1975) concerning the 
detrimental effect of dexamethasone upon lymphokine production and 
macrophage function. 
The use of isolated lymphocyte microcultures in this study has 
provided several observations that seem to conflict with results 
reported by other investigators. Rouse and Babiuk (1974a) indicated 
that specific IBRV antigen immunostimulâtion of isolated lymphocytes 
occurred at 4-6 days post IBRV infection and waned to undetectable 
levels by 14 days post infection. Their report was supported by the 
investigations of Reggiardo (1975). I was not able to detect such 
early stimulation in isolated lymphocyte microcultures when stimulation 
indices of less than 2.0 were discarded as being nonsignificant. My 
decision to use such a breaking point was based upon the fact that 
cultures from nonsensitized animals often approached such index levels 
due to day to day variations. It should be noted that the use of an 
index level below 2,0 as being no indication of stimulation would 
essentially eliminate the early stimulatory effect reported in their 
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studies. Rouse and Babiuk (1974a) reported high Sis of 10-18 in cattle 
with long-standing immunity, a situation that we were able to confirm 
following repeated skin testing or recrudescence with corticosteroids. 
If the specific antigen immunostimulation represents an ^  vitro 
cell mediated immune response then one would suspect that the evidence 
of sensitivity would not rise as early as these investigators have 
indicated and would remain well beyond the 14-day time indicated as 
undetectable. Furthermore, continued presence of the antigens and 
intradermal injections should heighten the response, a situation 
confirmed by our results. 
The use of specific IBRV antigens to stimulate whole blood cultures 
prepared from IBRV infected cattle was first reported by Davies and 
Carmichael (1973) to be an acceptable method of studying cell mediated 
immunity and its role in primary and recurrent infections. Their report 
indicated that the early response (4-6 days) after primary infections 
waned to nondetectable levels by 14 days post exposure. The results of 
experiments I conducted indicate that even though the initial immuno­
stimulation occurs as early as 6 days post exposure the specific immuno­
stimulation remained positive throughout an entire year without restimu­
lation. Whether the system I adapted for harvesting cultures was 
responsible or not, the pattern noted in these results is more compatible 
with the long-standing duration of other indications of cell-mediated 
immunity such as DTH response. The reasons for the difference in 
experimental results are not obvious. One possible explanation may be 
that the isolated lymphocyte technique may not be sensitive enough 
to detect subtle changes and are, therefore, only detecting the peak 
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response soon after infection. Another possibility is that the response 
detected early in both lymphocyte and whole blood cultures may not be 
directly related to CMI but may be evidence of some other immune response 
such as the Jones-Mote reaction. 
An overall view of the specific antigen-induced and nonspecific 
plant mitogen-induced (PHA-M) immunostimulâtion of whole blood and 
isolated lymphocyte cultures during dexamethasone and cyclophosphamide 
treatment provides a tool for dissecting the immune mechanism responsible 
for maintaining latent IBRV infections in cattle. If we can assume that 
nonspecific immunostimulation of lymphocyte and whole blood cultures with 
PHA-M is due principally to the blastogenic response of T lymphocytes 
in the culture then the decreased PHA-M mitogenic response following 
dexamethasone treatment as it occured in these experiments is to be 
expected. The unexpected response in these experiments is the fact 
that specific IBRV antigenic blastogenesis rises during the period 
of dexamethasone-induced IBRV recrudescence. Even though several 
times the normal amount of whole blood had to be processed to allow 
for adequate lymphocyte harvest, the sensitivity of the cells to 
respond to the specific mitogen remained. Shortman and Jackson (1974) 
have shown that there are at least 2 sub-populations of T lymphocytes 
in mice. One, the long-lived sub-population, is cortisone-resistant 
whereas the other, a short-lived population, is cortisone-sensitive. 
Others (Greaves et al. 1973) indicate that evidence for T lymphocyte 
sub-populations in other animals is strong. It appears that in cattle 
the PHA-M induced blastogenic response resides in the short-lived or 
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corticosteroid sensitive population whereas the specific IBRV antigen 
sensitivity apparently resides in the corticosteroid resistant 
sub-population. 
These findings and the data suggested assumptions can then be 
integrated into a plausible theory of the mechanisms involved in main­
taining the delicate host cell-virus relationship in chronically IBRV 
infected cattle. This theory coupled with the knowledge of the action 
of corticosteroids upon phagocytes and immunocytes can be used to 
explain potential mechanisms involved in dexamethasone-induced IBRV 
recrudescence. 
The chronic infection represented by slow replication of IBRV in 
slowly metabolizing cells produce herpesvirus-directed surface membrane 
antigens as viral replication proceeds. These antigens attract specif­
ically sensitized T lymphocytes (the dexamethasone resistant sub-
population) which subsequently attract macrophages and other T lymphocytes 
(nonsensitized, PHA-M immunoresponsive, dexamethasone sensitive lympho­
cytes) of the cytotoxic type. Through lymphokine and interferon 
production and the combined effects of T lymphocyte and activated macro­
phage accumulation, the infected cell is destroyed and releases infective 
viral particles that are immediately neutralized by specific humoral 
antibody. Such a theory becomes more palatable when combined with the 
previously reported results that indicate that the principal mode of 
immunosuppressive action of corticosteroids is upon the macrophage, whose 
digestive capacity is depressed by the drug. The inhibition of inter­
feron and lymphokine production and the inhibition of the cytotoxic 
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or (killer) T lymphocyte action is also impaired by corticosteroids 
perhaps by destroying biologically active substances produced by the 
macrophage that play a major role in T lymphocyte-macrophage interactions. 
The known mode of action of corticosteroids may fit into our proposed 
theory conveniently not by depressing the IBRV antigen sensitive cells 
but by inhibition of lymphokine (MIF, MAF) production in cells after 
they have been attracted to the area. (This contention would also 
explain the findings of numerous mononuclear cells in the skin test site 
even though the DTH response is severely depressed.) The dexamethasone-
induced depletion of the cytotoxic T lymphocytes (the PHA-M responsive 
sub-population) and the depression of macrophage digestive function and 
interferon production would allow for contiguous spread to adjacent 
cells without the extracellular exposure to antibody. 
The failure of severe cyclophosphamide-induced immunosuppression 
to cause recurrent IBRV lesions and nasal mucus secretion is logically 
explained by this theory. The primary effect of the drug seemed to be 
upon the neutrophil and B lymphocyte, thus basic cell mediated immune 
responses were not interrupted. 
These studies emphasize the need to focus scientific attention on the 
cell-mediated immune response as a measure of IBRV resistance rather than 
the classic idea of the presence of serum-virus neutralizing antibody 
being equated with resistance. They further seem to emphasize the need to 
seek to enhance the cell mediated immune response in immunizing procedures. 
They should also serve to remind us that we can expect recurrent infec­
tions with modified live virus vaccines in immunosuppressed conditions. 
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SUMMARY 
Dexamethasone treatment of chronically IBRV-infected cattle resulted 
in recrudescence of necrotic lesions of the respiratory tract and the 
secretion of IBRV in the nasal mucus. Reactivation of latent infections 
was produced with dexamethasone treatment at 3, 6, and 12 months after 
initial IBRV exposure. 
The pretreatment of calves with dexamethasone and subsequent 
intranasal exposure to IBRV and continued dexamethasone treatment 
caused death due to widely disseminated IBRV infection. The drug caused 
neutrophilia and lymphopenia and had a distinct depressive effect upon 
the percent of T lymphocytes in the peripheral blood. Data indicated 
that two distinct T lymphocyte sub-populations existed, cne sensitive 
and one more resistant to dexamethasone treatment. The dexamethasone 
sensitive sub-population was more responsive to PHA-M and the severe 
depletion of this sub-population coincided with the time of IBRV 
recrudescence. 
Whole blood cultures were more useful than isolated lymphocyte 
microcultures in detecting the cell mediated immune response after 
acute IBRV infections. Specific IBRV antigen immunostimulation of whole 
blood cultures rose to high levels by 6 days post treatment. The 
response was sustained in chronically infected animals for 1 year without 
further stimulation, a finding that refutes the contention of other 
investigators that it drops to undetectable levels within 14 days following 
initial exposure. 
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The techniques used in isolated lymphocyte microcultures failed to 
provide evidence of specific IBRV antigen-induced blastogenesis following 
initial exposure and could only be demonstrated following skin testing 
or drug-induced IBRV recrudescence. 
Cyclophosphamide treatment failed to cause IBRV recrudescence in 
chronically infected cattle. The failure of development of acute 
inflammation in response to microbial invasion of the epithelium and 
widespread histopathological evidence of lymphoid depletion indicated 
that the drug caused severe immunodepression. The principal effect 
of the drug seemec^  to be upon the neutrophil and the B lymphocyte. 
The use of different immunosuppressants, dexamethasone and 
cyclophosphamide, provided a mechanism whereby the immune mechanisms 
of cattle could be segmented and evaluated separately. 
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